CN105154466B - A kind of double gene coexpression recombinant vector and its construction method and the application in Blakeslea trispora - Google Patents
A kind of double gene coexpression recombinant vector and its construction method and the application in Blakeslea trispora Download PDFInfo
- Publication number
- CN105154466B CN105154466B CN201510491355.XA CN201510491355A CN105154466B CN 105154466 B CN105154466 B CN 105154466B CN 201510491355 A CN201510491355 A CN 201510491355A CN 105154466 B CN105154466 B CN 105154466B
- Authority
- CN
- China
- Prior art keywords
- gene
- sequence
- syn
- hygr
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 116
- 239000013598 vector Substances 0.000 title claims abstract description 99
- 238000010276 construction Methods 0.000 title claims abstract description 17
- 241000235553 Blakeslea trispora Species 0.000 title abstract description 39
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 title description 3
- 239000013612 plasmid Substances 0.000 claims abstract description 50
- 230000014509 gene expression Effects 0.000 claims abstract description 45
- 238000010367 cloning Methods 0.000 claims abstract description 30
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000002773 nucleotide Substances 0.000 claims abstract description 15
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 13
- 241000233866 Fungi Species 0.000 claims abstract description 12
- 230000003321 amplification Effects 0.000 claims description 31
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 31
- 108091008146 restriction endonucleases Proteins 0.000 claims description 14
- 230000029087 digestion Effects 0.000 claims description 9
- 108700005078 Synthetic Genes Proteins 0.000 claims description 2
- 101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 claims 1
- 102100034866 Kallikrein-6 Human genes 0.000 claims 1
- 238000004064 recycling Methods 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 abstract description 6
- 241000193830 Bacillus <bacterium> Species 0.000 abstract 1
- 239000000047 product Substances 0.000 description 25
- 229930193140 Neomycin Natural products 0.000 description 23
- 239000012634 fragment Substances 0.000 description 23
- 229960004927 neomycin Drugs 0.000 description 23
- 101150028535 CRTZ gene Proteins 0.000 description 22
- 238000000034 method Methods 0.000 description 19
- 230000009466 transformation Effects 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 16
- 230000004186 co-expression Effects 0.000 description 15
- 241000589158 Agrobacterium Species 0.000 description 12
- 230000002457 bidirectional effect Effects 0.000 description 11
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 10
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 10
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 10
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 10
- 239000013604 expression vector Substances 0.000 description 10
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 10
- 235000010930 zeaxanthin Nutrition 0.000 description 10
- 239000001775 zeaxanthin Substances 0.000 description 10
- 229940043269 zeaxanthin Drugs 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 238000001976 enzyme digestion Methods 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 230000002068 genetic effect Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 238000012795 verification Methods 0.000 description 8
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 7
- 238000005520 cutting process Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 238000001962 electrophoresis Methods 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 238000000246 agarose gel electrophoresis Methods 0.000 description 6
- 238000000137 annealing Methods 0.000 description 6
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 6
- 229960002727 cefotaxime sodium Drugs 0.000 description 6
- 238000004925 denaturation Methods 0.000 description 6
- 230000036425 denaturation Effects 0.000 description 6
- 238000012257 pre-denaturation Methods 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 3
- 235000013734 beta-carotene Nutrition 0.000 description 3
- 239000011648 beta-carotene Substances 0.000 description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 3
- 229960002747 betacarotene Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 3
- 241000351920 Aspergillus nidulans Species 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 241000588698 Erwinia Species 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 101100370749 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) trpC1 gene Proteins 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 108010091656 beta-carotene hydroxylase Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 101150089818 carRA gene Proteins 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000012239 gene modification Methods 0.000 description 2
- 230000030279 gene silencing Effects 0.000 description 2
- 230000005017 genetic modification Effects 0.000 description 2
- 235000013617 genetically modified food Nutrition 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 108060004506 lycopene beta-cyclase Proteins 0.000 description 2
- 108060004507 lycopene cyclase Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 108010001545 phytoene dehydrogenase Proteins 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 101150016309 trpC gene Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- 241001223281 Peronospora Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 102000006646 aminoglycoside phosphotransferase Human genes 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000011681 asexual reproduction Effects 0.000 description 1
- 238000013465 asexual reproduction Methods 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- -1 deoxyribose nucleic acids Chemical group 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 235000003869 genetically modified organism Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940116736 romycin Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
技术领域technical field
本发明涉及基因技术领域,具体地说是一种双基因共表达重组载体及其构建方法和在丝状真菌三孢布拉霉中的应用。The invention relates to the field of gene technology, in particular to a dual-gene co-expression recombinant vector and its construction method and application in the filamentous fungus B. trispora.
背景技术Background technique
常规转基因多是利用单个目的基因改良生物的个别性状,但单个目的基因的转化不能满足生物改良的需要,尤其是对一些代谢途径或数量性状的遗传修饰。随着基因工程和分子生物学研究的深入,多基因转化研究应运而生,并迅速发展。Conventional transgenics mostly use a single target gene to improve individual traits of organisms, but the transformation of a single target gene cannot meet the needs of biological improvement, especially the genetic modification of some metabolic pathways or quantitative traits. With the deepening of genetic engineering and molecular biology research, multi-gene transformation research came into being and developed rapidly.
生物遗传转化多基因共表达系统通常包括多质粒共转化系统和单个载体表达多个基因表达盒系统。在多质粒共转化系统中,是将多个外源基因分别克隆至不同的抗性载体中,共转化后同时添加多种抗生素实现多基因的共表达,由于受到抗性标记种类及组合方式的限制,这种系统仅能实现少数几个基因的共表达。此外,共表达时,还需要考虑多个表达质粒的相容性,操作起来也比较麻烦,且转化效率不高。可见,单个载体表达多个基因表达盒系统更具研究和应用价值。The multi-gene co-expression system for biological genetic transformation usually includes a multi-plasmid co-transformation system and a single vector expression cassette system for multiple genes. In the multi-plasmid co-transformation system, multiple foreign genes are respectively cloned into different resistance vectors, and multiple antibiotics are added at the same time after co-transformation to realize the co-expression of multiple genes. However, this system can only achieve the co-expression of a few genes. In addition, when co-expressing, the compatibility of multiple expression plasmids needs to be considered, and the operation is cumbersome, and the transformation efficiency is not high. It can be seen that a single vector expressing multiple gene expression cassette systems has more research and application value.
基因表达载体是指实施了目的基因,并且保证目的基因到达受体细胞能够表达的运载体,基因表达载体的构成是在运载体的基础上构建的,基因表达载体所必须具备的组成是启动子+目的基因+终止子+标记基因。多基因表达载体即可用于多个基因插入,能让多个目的基因到达受体细胞并表达的载体。The gene expression carrier refers to the carrier that implements the target gene and ensures that the target gene reaches the recipient cell and can be expressed. The composition of the gene expression carrier is constructed on the basis of the carrier. The necessary component of the gene expression carrier is the promoter +target gene+terminator+marker gene. A multi-gene expression vector can be used for multiple gene insertion, allowing multiple target genes to reach and express in recipient cells.
基因表达载体的构建是基因工程的核心,是将目的基因与运载体结合的过程,实际上是不同来源的DNA重新组合的过程。通常是以分子遗传学为理论基础,以分子生物学和微生物学的现代方法为手段,将不同来源的基因按预先设计的蓝图,在体外构建杂种DNA分子,然后导入活细胞,以改变生物原有的遗传特性、获得新品种、生产新产品。该过程如果以质粒作为运载体,首先要用一定的限制酶切割质粒,使质粒出现一个缺口,露出黏性末端;然后用同一种限制酶切断目的基因,使其产生相同的黏性末端(部分限制性内切酶可切割出平末端,拥有相同效果);将切下的目的基因的片段插入质粒的切口处,首先碱基互补配对结合,两个黏性末端吻合在一起,碱基之间形成氢键,再加入适量DNA连接酶,催化两条DNA链之间形成磷酸二酯键,从而将相邻的脱氧核糖核酸连接起来,形成一个重组DNA分子。如人的胰岛素 基因就是通过这种方法与大肠杆菌中的质粒DNA分子结合,形成重组DNA分子(也叫重组质粒)的。The construction of gene expression vector is the core of genetic engineering, which is the process of combining the target gene with the carrier, in fact, the process of recombining DNA from different sources. Usually based on the theory of molecular genetics and modern methods of molecular biology and microbiology, genes from different sources are used to construct hybrid DNA molecules in vitro according to a pre-designed blueprint, and then introduced into living cells to change the biological origin. Some genetic traits, acquisition of new varieties, production of new products. If a plasmid is used as a carrier in this process, it is first necessary to cut the plasmid with a certain restriction enzyme to make a gap in the plasmid and expose the sticky end; then use the same restriction enzyme to cut the target gene to produce the same sticky end (part Restriction endonucleases can cut out blunt ends, which have the same effect); insert the excised fragment of the target gene into the nick of the plasmid, first base complementary pairing, the two sticky ends are anastomosed together, and the bases Form hydrogen bonds, and then add an appropriate amount of DNA ligase to catalyze the formation of phosphodiester bonds between the two DNA strands, thereby linking adjacent deoxyribose nucleic acids to form a recombinant DNA molecule. For example, the human insulin gene is combined with the plasmid DNA molecule in Escherichia coli to form a recombinant DNA molecule (also called a recombinant plasmid) through this method.
目前,基因工程领域内所构建的表达载体多为原核和植物表达载体,如PUC-T为经常用到的原核表达载体,但是不适合真核生物,而且常用的植物表达载体如PBI121、PBI221等在真菌中使用也受到一定的局限性。此外,技术人员通常想要外源基因表达时需选择合适的酶切位点借助酶切连接进行外源基因的插入使其转化宿主得以表达。而现有技术中,本领域对于丝状真菌表达载体构建的研究较少,尤其专门针对于三孢布拉霉基因表达载体的构建更是鲜有报道。At present, most of the expression vectors constructed in the field of genetic engineering are prokaryotic and plant expression vectors. For example, PUC-T is a frequently used prokaryotic expression vector, but it is not suitable for eukaryotes, and commonly used plant expression vectors such as PBI121, PBI221, etc. The use in fungi is also subject to certain limitations. In addition, when a technician wants to express an exogenous gene, he usually needs to select a suitable restriction site for insertion of the exogenous gene by means of an restriction enzyme connection so that the transformed host can be expressed. However, in the prior art, there are few studies on the construction of expression vectors for filamentous fungi in this field, especially for the construction of gene expression vectors for B. trispora.
三孢布拉霉属于霜霉目、白锈科,拉丁名是Blakeslea trispora,是目前大规模工业化生产天然β-胡萝卜素的主要菌种。该菌在使用过程中常需要对其进行遗传修饰,其过程基本为:(1)扩增所需插入片段,(2)做T载体克隆进行酶切,(3)通过酶切连接进行载体的构建。如,对三孢布拉霉进行修饰时常用的载体中有PCAMBIAI1303,所用启动子为CaMV35Spromoter,由于质粒上仅含有一个多克隆位点,其不能将PCR产物直接用于连接。又如,李继刚等研究了丝状真菌转化载体的改进(河南农业科学,2013年05期),报道了pATZ、pTBZ的构建过程,通过酶切连接所改进的载体含有抗性标记和多克隆位点,但是,如果想要实现外源基因的表达,也需通过酶切连接的方式加上启动子,终止子和相应的目的基因,而且在插入目标基因时,很难找到合适的酶切位点,而且有些酶活性较低,会给操作带来很大麻烦。再如,CN1759174A公开了遗传修饰布拉霉属生物的方法、相应的生物及其用途,利用pBinA载体构建了pBinAHygR载体,该载体含有潮霉素抗性和一个介于启动子和终止子之间的多克隆位点,选择合适的酶切位点利用酶切连接的方式可在多克隆位点处插入任意一个基因,构建好要表达的载体,然后运用农杆菌介导的方式,转化三孢布拉霉中的至少一个细胞,通过诱变等方式进行同核转变,使一个或多个细胞都获得一样的遗传性状,以使其得到稳定遗传,但是,其仅限于加入单个基因,如果想表达多个基因还需加入多个启动子,则需多次借助外源载体进行连接,或通过共转化才能得以实现,其不仅操作过程繁琐复杂,而且容易导致基因表达量不一致、反义失活以及遗传不稳定;此外,对插入含有多个酶切位点的长片段目标基因也造成一定困难。Blakeslea trispora belongs to the order Peronospora, Albiraceae, and its Latin name is Blakeslea trispora. It is currently the main strain for large-scale industrial production of natural β-carotene. The bacteria often need to be genetically modified during use, and the process is basically: (1) amplify the required insert, (2) clone the T vector for enzyme digestion, (3) construct the vector by enzyme digestion and ligation . For example, PCAMBIAI1303 is the commonly used vector for modifying B. trispora, and the promoter used is CaMV35Spromoter. Since the plasmid contains only one multiple cloning site, the PCR product cannot be directly used for ligation. As another example, Li Jigang et al. studied the improvement of filamentous fungal transformation vectors (Henan Agricultural Sciences, 2013, Issue 05), and reported the construction process of pATZ and pTBZ. The improved vectors contained resistance markers and multiple cloning sites by restriction enzyme ligation point, but if you want to achieve the expression of foreign genes, you also need to add promoters, terminators and corresponding target genes by enzyme-cut ligation, and it is difficult to find a suitable enzyme-cut site when inserting the target gene point, and some enzymes have low activity, which will bring great trouble to the operation. For another example, CN1759174A discloses a method for genetically modifying Brailletella organisms, corresponding organisms and uses thereof. The pBinAHygR vector is constructed using the pBinA vector, which contains hygromycin resistance and a The multiple cloning site, select the appropriate enzyme cutting site, insert any gene at the multiple cloning site by enzyme cutting and ligation, construct the vector to be expressed, and then use the Agrobacterium-mediated method to transform the three spora At least one cell in B. boulardii undergoes homokaryon transformation through mutagenesis, so that one or more cells can obtain the same genetic traits, so that they can be inherited stably. However, it is limited to the addition of a single gene. If you want to To express multiple genes, multiple promoters need to be added, which requires multiple connections with foreign vectors or co-transformation, which is not only cumbersome and complicated, but also easily leads to inconsistent gene expression and antisense inactivation And genetic instability; in addition, it also causes certain difficulties to insert long fragments of target genes containing multiple restriction sites.
发明内容Contents of the invention
本发明的目的就是提供一种双基因共表达重组载体及其构建方法和在三孢布拉霉中的应用,以解决现有的表达载体所存在表达两个以上基因时需要进行多次外源基因的整合,操作繁琐,以及基因表达量不一致、反义失活以及遗传不稳定等问题。The purpose of the present invention is to provide a double-gene co-expression recombinant vector and its construction method and application in B. trispora to solve the existing expression vector needs to carry out multiple exogenous The integration of genes is cumbersome to operate, as well as problems such as inconsistent gene expression, antisense inactivation, and genetic instability.
本发明的目的是通过以下技术方案实现的:The purpose of the present invention is achieved through the following technical solutions:
一种双基因共表达重组载体,以初始载体为骨架携带有完整的基因表达框序列syn,所述序列syn含有:终止子序列(Ter)—多克隆位点(MCS)—双向启动子序列PCarB—TA克隆制备序列—终止子序列(Ter),该基因syn的核苷酸序列如SEQ ID NO:1所示;A double-gene co-expression recombinant vector, with the initial vector as the backbone carrying a complete gene expression cassette sequence syn, the sequence syn contains: terminator sequence (Ter) - multiple cloning site (MCS) - bidirectional promoter sequence PCarB —TA clone preparation sequence—terminator sequence (Ter), the nucleotide sequence of the gene syn is shown in SEQ ID NO:1;
其中终止子(Ter)、多克隆位点(MCS)、双向启动子PCarB、TA克隆位点、终止子(Ter)各自的分子量大小依次为559bp、43bp、610bp、28bp、559bp,在核苷酸序列SEQ.ID.NO:1上从前到后依次排列。The molecular weights of the terminator (Ter), the multiple cloning site (MCS), the bidirectional promoter PCarB, the TA cloning site, and the terminator (Ter) are 559bp, 43bp, 610bp, 28bp, and 559bp in sequence. The sequence SEQ.ID.NO:1 is arranged from front to back.
所述初始载体为pATZ、pPZP100、pPZP101、pPZP102、pPZP111、pPZP112、pPZP121、pPZP122、pPZP200、pPZP201、pPZP202、pPZP211、pPZP212、pPZP221或pPZP222中的任意一种;优选为pATZ。The initial vector is any one of pATZ, pPZP100, pPZP101, pPZP102, pPZP111, pPZP112, pPZP121, pPZP122, pPZP200, pPZP201, pPZP202, pPZP211, pPZP212, pPZP221 or pPZP222;
本发明构建了一种丝状真菌表达一个或同时表达两个外源基因的重组载体,通过在双向启动子一侧加入多克隆位点,另一侧加入TA克隆,使外源基因的导入操作更方便快捷;通过在丝状真菌三孢布拉霉的应用实验证明,在重组载体上同时添加上两个目标基因,并通过农杆菌介导可以整合到三孢布拉霉基因组中,以单拷贝插入,稳定遗传。The present invention constructs a recombinant vector for expressing one or two exogenous genes in a filamentous fungus. By adding multiple cloning sites on one side of the bidirectional promoter and adding TA clones on the other side, the introduction of exogenous genes can It is more convenient and fast; the application experiment in the filamentous fungus B. trispora has proved that two target genes can be added to the recombinant vector at the same time, and can be integrated into the genome of B. trispora through the mediation of Agrobacterium. Copy insertion, stable inheritance.
本发明提供的双基因共表达重组载体在所述载体中还携带有潮霉素抗性基因hygR,可作为重组子筛选的标记基因,所述潮霉素抗性基因hygR的核苷酸序列如SEQ.ID.NO:2所示。The double-gene co-expression recombinant vector provided by the present invention also carries the hygromycin resistance gene hygR in the vector, which can be used as a marker gene for recombinant selection. The nucleotide sequence of the hygromycin resistance gene hygR is as follows: Shown in SEQ.ID.NO:2.
本发明还提供了一种双基因共表达重组载体pPMPT,以初始载体pATZ为骨架携带有基因表达框序列syn,并以潮霉素抗性基因hygR作为筛选标记基因,所述基因表达框序列syn含有:终止子序列(Ter)—多克隆位点(MCS)—双向启动子序列PCarB—TA克隆制备序列—终止子序列(Ter),其核苷酸序列如SEQ ID NO:1所示;所述潮霉素抗性基因hygR的核苷酸序列如SEQ.ID.NO:2所示;其质粒图谱为:The present invention also provides a dual-gene co-expression recombinant vector pPMPT, which carries the gene expression cassette sequence syn with the initial vector pATZ as the backbone, and uses the hygromycin resistance gene hygR as a selection marker gene, and the gene expression cassette sequence syn Contains: terminator sequence (Ter)—multiple cloning site (MCS)—bidirectional promoter sequence PCarB—TA clone preparation sequence—terminator sequence (Ter), the nucleotide sequence of which is shown in SEQ ID NO:1; The nucleotide sequence of the hygromycin resistance gene hygR is shown in SEQ.ID.NO:2; its plasmid map is:
所述重组载体pPMPT的核苷酸序列如SEQ ID NO:3所示。The nucleotide sequence of the recombinant vector pPMPT is shown in SEQ ID NO:3.
本发明提供的双基因共表达重组载体pPMPT的构建方法,包括以下步骤:The construction method of the double-gene co-expression recombinant vector pPMPT provided by the invention comprises the following steps:
(a)按照如SEQ ID NO:1所示的核苷酸序列人工合成完整的基因表达框序列syn,并克隆于载体pMD19-T中,得质粒pMD19-T-syn;(a) Artificially synthesize a complete gene expression cassette sequence syn according to the nucleotide sequence shown in SEQ ID NO:1, and clone it into the vector pMD19-T to obtain the plasmid pMD19-T-syn;
(b)扩增潮霉素抗性基因hygR,将其克隆于载体pMD19-T中,得质粒pMD19-T-hygR;(b) amplify the hygromycin resistance gene hygR, and clone it into the vector pMD19-T to obtain the plasmid pMD19-T-hygR;
(c)将所述质粒pMD19-T-hygR和质粒pMD19-T-syn分别以SalⅠ限制性内切酶进行酶切,回收酶切产物pMD19-T-hygR和syn两片段,16℃连接过夜,得pMD19-T-hygR-syn;(c) Digest the plasmid pMD19-T-hygR and the plasmid pMD19-T-syn respectively with SalI restriction endonuclease, recover the two fragments of the digested product pMD19-T-hygR and syn, and ligate overnight at 16°C, Get pMD19-T-hygR-syn;
(d)将pMD19-T-hygR-syn和初始载体pATZ分别以BssHⅡ和HindⅢ限制性内切酶双酶切,回收酶切产物hygR-syn片段和质粒pATZ酶切后剩余的含有T-DNA的部分,将回收的两个片段在16℃下连接过夜,连接产物转化大肠杆菌DH5α,得到质粒pATZ-hygR-syn,命名为重组载体pPMPT。(d) Digest pMD19-T-hygR-syn and initial vector pATZ with BssHII and HindIII restriction endonucleases respectively, recover the hygR-syn fragment of the digested product and the remaining T-DNA-containing fragment after digestion of plasmid pATZ Part, the two recovered fragments were ligated overnight at 16°C, and the ligated product was transformed into Escherichia coli DH5α to obtain the plasmid pATZ-hygR-syn, which was named as the recombinant vector pPMPT.
构建过程如图15所示。The build process is shown in Figure 15.
本发明公开的重组载体pPMPT中完整的基因表达框序列syn为人工合成的一段序列,其包括:终止子序列(Ter)—多克隆位点(MCS)—双向启动子序列PCarB—TA克隆制备序列(AhdⅠ,SpeⅠ,AhdⅠ)—终止子序列(Ter),合成该序列时上游引物5'端添加SalⅠ酶切位点,下游引物3'端依次添加HindⅢ和SalⅠ酶切位点。The complete gene expression cassette sequence syn in the recombinant vector pPMPT disclosed by the present invention is a synthetic sequence, which includes: terminator sequence (Ter)—multiple cloning site (MCS)—bidirectional promoter sequence PCarB—TA clone preparation sequence (AhdI, SpeI, AhdI)—terminator sequence (Ter), when the sequence is synthesized, a SalI restriction site is added to the 5 ' end of the upstream primer, and a HindIII and SalI restriction site is added to the 3 ' end of the downstream primer in sequence.
其始末两个终止子序列均来自构巢曲霉中的trpC terminator,在丝状真菌和植物中具有终止功能,其大小为559bp,位于基因表达框序列syn中的始端和末端。在最终构建好的载体序列SEQ ID NO:3中的信息为:Both the beginning and the end of the terminator sequence are from the trpC terminator in Aspergillus nidulans, which has a termination function in filamentous fungi and plants. Its size is 559bp, and it is located at the beginning and end of the gene expression frame sequence syn. The information in the final constructed vector sequence SEQ ID NO:3 is:
Ter 9034-9592 559 misc featureTer 9034-9592 559 misc feature
Ter 10274-10832 559 misc featureTer 10274-10832 559 misc feature
其多克隆位点(MCS)所含有的限制性内切酶依次为XbaⅠ,BstEⅡ,SacⅠ,KpnⅠ,SmaⅠ,MfeⅠ,BglⅡ,可通过酶切连接的方式根据需要加入要表达的外源基因片段,由于前后两端含有相应的启动子和终止子,故若插入为正向则可直接表达;克隆位点(MCS)大小为43bp,在完整的基因表达框序列syn中的第560位到第602位,在最终构建好的载体中序列信息为:The restriction endonucleases contained in its multiple cloning site (MCS) are XbaI, BstEII, SacI, KpnI, SmaI, MfeI, BglII in sequence, and the exogenous gene fragments to be expressed can be added according to the needs by enzyme cutting and ligation. Since the front and back ends contain corresponding promoters and terminators, it can be directly expressed if the insertion is in the forward direction; the size of the cloning site (MCS) is 43bp, and it is located at the 560th to 602nd position in the complete gene expression frame sequence syn bit, the sequence information in the final constructed vector is:
MCS 9593-9635 43 misc featureMCS 9593-9635 43 misc feature
其双向启动子PCarB序列来源为三孢布拉霉中启动八氢番茄红素脱氢酶基因(carB)和番茄红素环化酶基因(carRA)的启动子序列。该启动子具有双向启动功能,可启动其上游和下游基因序列的表达,其分子量大小为610bp,在基因syn中的第603位到第1212位,在最终构建好的载体中序列信息:The sequence source of its bidirectional promoter PCarB is the promoter sequence of phytoene dehydrogenase gene (carB) and lycopene cyclase gene (carRA) in B. trispora. The promoter has a bidirectional start function and can start the expression of its upstream and downstream gene sequences. Its molecular weight is 610bp, and it is located at the 603rd to 1212th position in the gene syn. The sequence information in the final constructed vector is as follows:
PCarB 9636-10245 610 misc featurePCarB 9636-10245 610 misc feature
其TA克隆制备序列,本载体中TA克隆的制备时采用酶切的方式直接制备,其分子量大小为28bp,在基因syn中的第1213位到1240位,在最终构建好的载体中序列信息:Its TA clone preparation sequence, the preparation of the TA clone in this vector is directly prepared by enzyme digestion, its molecular weight is 28bp, and it is in the 1213th to 1240th position in the gene syn, and the sequence information in the final constructed vector is:
TA 克隆 10246-10273 28 misc featureTA clone 10246-10273 28 misc feature
将以上碱基片段人工合成,命名为基因表达框序列syn,本发明中该人工片段由金唯智生物科技有限公司合成,且由puc57载体携带,即质粒puc57-syn。The above base fragment was artificially synthesized and named the gene expression frame sequence syn. In the present invention, the artificial fragment was synthesized by Jinweizhi Biotechnology Co., Ltd. and carried by the puc57 vector, namely the plasmid puc57-syn.
本发明步骤(d)中初始载体pATZ的构建方法见“丝状真菌转化载体的改进”(李继刚等,《河南农业学报》,2013,42(5):110-113)。For the construction method of the initial vector pATZ in step (d) of the present invention, see "Improvement of Transformation Vectors for Filamentous Fungi" (Li Jigang et al., "Journal of Henan Agricultural Sciences", 2013, 42(5): 110-113).
本发明对构建的重组载体pPMPT在三孢布拉霉中的适用性进行了验证。通过BglⅡ和XbaⅠ将外源基因neoR导入质粒pPMPT的多克隆位点(MCS),通过TA克隆将外源基因crtZ导入质粒pPMPT的TA克隆位点,将所构建质粒以农杆菌介导的方法转化三孢布拉霉进行验证外源基因整合到基因组中是否能够正常表达及稳定遗传。将转化子在潮霉素抗性板上进行4-5 次传代,挑取最终抗性板上生长的三孢布拉霉进行DNA提取,扩增潮霉素抗性基因以及插入的外源基因neoR和crtZ,验证外源基因是否整合到了三孢布拉霉的基因组中,进而通过新霉素抗性试验以检测外源基因新霉素抗性基因(neoR)是否表达;通过发酵三孢布拉霉并提取发酵产物中的色素物质进行HPLC分析以检测外源基因crtZ是否表达。crtZ基因能表达β-胡萝卜素羟化酶,可将三孢布拉霉的终产物β-胡萝卜素进一步转变为玉米黄质。经HPLC分析,三孢布拉霉转化子的发酵产物中检测到了玉米黄质的存在。因此,我们得到了抗新霉素且积累玉米黄质的三孢布拉霉工程菌株,并可通过无性孢子稳定遗传下去,证明了该重组载体将两个目标基因转入三孢布拉霉实现外源基因共表达的目的和用途。The present invention verifies the applicability of the constructed recombinant vector pPMPT in B. trispora. The exogenous gene neoR was introduced into the multiple cloning site (MCS) of plasmid pPMPT by BglII and XbaI, and the exogenous gene crtZ was introduced into the TA cloning site of plasmid pPMPT by TA cloning, and the constructed plasmid was transformed by the method mediated by Agrobacterium B. trispora was used to verify the normal expression and stable inheritance of exogenous genes integrated into the genome. Passage the transformant on the hygromycin resistance plate for 4-5 times, pick the B. trispora grown on the final resistance plate for DNA extraction, and amplify the hygromycin resistance gene and the inserted foreign gene neoR and crtZ, verify whether the exogenous gene is integrated into the genome of B. trispora, and then pass the neomycin resistance test to detect whether the exogenous gene neomycin resistance gene (neoR) is expressed; Pull the mold and extract the pigment substances in the fermentation product for HPLC analysis to detect whether the exogenous gene crtZ is expressed. The crtZ gene can express β-carotene hydroxylase, which can further convert β-carotene, the final product of B. trispora, into zeaxanthin. Through HPLC analysis, the presence of zeaxanthin was detected in the fermentation product of the B. trispora transformant. Therefore, we obtained an engineering strain of B. trispora that is resistant to neomycin and accumulates zeaxanthin, and can be stably inherited through asexual spores, which proves that the recombinant vector can transfer two target genes into B. trispora The purpose and use of foreign gene co-expression.
本发明构建的载体是在一个双元Ti载体pATZ的基础上进行的改造,对载体pATZ的序列进行分析,首先人工合成一段完整的基因表达框序列syn,这段合成的序列包含终止子序列(Ter)—多克隆位点(MCS)—双向启动子序列PCarB—TA克隆制备序列—终止子序列(Ter),利用酶切连接的方法,将syn序列和潮霉素抗性表达盒插入两个T-DNA区之间,最终构建了重组载体pPMPT。该载体由于含有双向启动子,并在双向启动子两侧分别加入TA克隆和多克隆位点,这样不管在TA克隆处还是多克隆位点处都可以添加外源表达基因片段,而且该载体中转化丝状真菌尤其是三孢布拉霉进行同核转变后,可比较轻松地实现单个外源基因或两个相关或不相关的外源基因同时在丝状真菌中的表达,也省去了寻找适当启动子并进行添加的过程。同时本发明还具有以下优点:The carrier constructed by the present invention is a transformation carried out on the basis of a binary Ti carrier pATZ. The sequence of the carrier pATZ is analyzed. First, a complete gene expression cassette sequence syn is artificially synthesized. This synthetic sequence includes a terminator sequence ( Ter)—multiple cloning site (MCS)—bidirectional promoter sequence PCarB—TA cloning preparation sequence—terminator sequence (Ter), using the method of enzyme digestion and ligation, insert the syn sequence and the hygromycin resistance expression cassette into two Between the T-DNA regions, the recombinant vector pPMPT was finally constructed. Since the vector contains a bidirectional promoter, TA cloning and multiple cloning sites are respectively added on both sides of the bidirectional promoter, so that no matter at the TA cloning site or the multiple cloning site, exogenous expression gene fragments can be added, and the vector contains Transformation of filamentous fungi, especially B. trispora, after homokaryotic conversion, can easily achieve the expression of a single exogenous gene or two related or unrelated exogenous genes in filamentous fungi at the same time. The process of finding an appropriate promoter and adding it. Simultaneously the present invention also has the following advantages:
1、本发明所构建的重组载体克服了在真核基因中实现双基因共表达时需要加入特定位点或在第二个基因前再加上一个启动子等繁琐工作的缺点;1. The recombinant vector constructed by the present invention overcomes the shortcomings of tedious work such as adding a specific site or adding a promoter before the second gene when realizing double-gene co-expression in eukaryotic genes;
2、能够避免因相似启动子同时加入导致同源重组引起的基因反式失活现象的发生;2. It can avoid the occurrence of gene trans-inactivation caused by homologous recombination caused by the simultaneous addition of similar promoters;
3、该重组载体含有多克隆位点,可借助酶切连接对不同基因片段进行插入,使表达盒的组装非常便捷;3. The recombinant vector contains multiple cloning sites, which can be inserted into different gene fragments by enzyme-cut ligation, making the assembly of the expression cassette very convenient;
4、该载体可以通过AhdⅠ内切酶的酶切消化,载体可产生TA克隆位点,故可对PCR产物直接进行连接,特别是对于一些含有较多限制性内切酶位点的外源基因片段,在进行酶切连接时经常找不到合适的酶切位点,这种含T的载体便显得更重要,操作更方便;4. The vector can be digested by AhdI endonuclease, and the vector can generate TA cloning sites, so the PCR product can be directly connected, especially for some foreign genes containing more restriction endonuclease sites Fragments, often can not find a suitable enzyme cutting site when performing enzyme digestion and connection, this T-containing vector is more important and more convenient to operate;
5、该载体含有两个T-DNA边界,可使用农杆菌介导的方法进行转化,提高转化效率,含有的潮霉素抗性可用于筛选阳性克隆子。5. The vector contains two T-DNA borders, which can be transformed using the Agrobacterium-mediated method to improve the transformation efficiency, and the hygromycin resistance contained can be used to screen positive clones.
通过实验证明,本发明构建的重组载体通过插入neoR基因和crtZ基因的编码区序列,转入三孢布拉霉后,得到了具有新霉素抗性并能表达玉米黄质的三孢布拉霉工程菌株,而且其遗传的稳定性良好,证明了重组载体pPMPT对三孢布拉霉进行外源基因的导入具有非常好的适 用性,同时,此载体在其他丝状真菌中也具有应用潜力。It has been proved by experiments that the recombinant vector constructed by the present invention is inserted into the coding region sequences of the neoR gene and the crtZ gene, and after being transformed into B. trispora, the B. trispora has neomycin resistance and can express zeaxanthin. Mold engineering strain, and its genetic stability is good, which proves that the recombinant vector pPMPT has very good applicability for the introduction of foreign genes to B. trispora. At the same time, this vector also has application potential in other filamentous fungi .
附图说明Description of drawings
图1为人工合成的完整基因表达框序列syn的酶切回收图谱;图中M为500bp DNALadder(北京溪洋汇智),1为syn。Figure 1 is the enzyme digestion and recovery map of the artificially synthesized complete gene expression cassette sequence syn; in the figure, M is 500bp DNALadder (Beijing Xiyang Huizhi), and 1 is syn.
图2为潮霉素抗性基因hygR表达盒的扩增电泳图谱;图中M1为DL5,000DNA Maker(大连宝生物),6为hygR的整个表达盒。Figure 2 is the amplified electrophoresis pattern of the hygR expression cassette of the hygromycin resistance gene; in the figure, M 1 is DL5,000 DNA Maker (Dalian Bao Biology), and 6 is the entire expression cassette of hygR.
图3为潮霉素抗性基因hygR表达盒的阳性克隆扩增检测验证;图中M2为500bp DNALadder(北京溪洋汇智),3为hygR的整个表达盒。Figure 3 is the verification of the positive clone amplification detection of the expression cassette of the hygromycin resistance gene hygR; in the figure, M 2 is a 500bp DNALadder (Beijing Xiyang Huizhi), and 3 is the entire expression cassette of hygR.
图4为扩增验证的正向连接的pMD19-T-hygR-syn的电泳图谱;图中M3为DL5,000DNA Maker(大连宝生物),4和5均为hygR-syn片段。Figure 4 is the electrophoretic pattern of forward-linked pMD19-T-hygR-syn verified by amplification; in the figure, M 3 is DL5,000 DNA Maker (Dalian Bao Biology), and 4 and 5 are hygR-syn fragments.
图5为扩增验证的阳性克隆pATZ-hygR-syn的电泳图谱;图中M4为DL5,000DNAMaker(大连宝生物),7为hygR-syn片段。Figure 5 is the electrophoretic pattern of the positive clone pATZ-hygR-syn verified by amplification; in the figure, M 4 is DL5,000 DNAMaker (Dalian Bao Biology), and 7 is the hygR-syn fragment.
图6为新霉素抗性基因neoR扩增的凝胶电泳图谱;图中M5为DL5,000DNA Maker(大连宝生物),8和9为不含启动子的新霉素抗性基因neoR,长度为816bp。Figure 6 is the gel electrophoresis pattern of neomycin resistance gene neoR amplification; in the figure, M 5 is DL5,000 DNA Maker (Dalian Bao Biology), 8 and 9 are neomycin resistance gene neoR without promoter, The length is 816bp.
图7为pPMPT质粒和含新霉素抗性基因neoR的T载体用BglⅡ和XbaⅠ进行双酶切酶切回收检测的电泳图谱;图中M6为500bp DNA Ladder(北京溪洋汇智),10为pPMPT酶切回收所得片段,长度为11161bp,11为neoR片段,长度为816bp。Figure 7 is the electrophoretic pattern of the pPMPT plasmid and the T vector containing neomycin resistance gene neoR with BglII and XbaI for double enzyme digestion and recovery detection; M 6 in the figure is a 500bp DNA Ladder (Beijing Xiyang Huizhi), 10 The fragment obtained by digestion with pPMPT is 11161bp in length, and 11 is a neoR fragment with a length of 816bp.
图8为pPMPT-neoR中新霉素抗性基因neoR阳性扩增验证电泳图;图中M7为DL5,000DNA Maker(大连宝生物),12和13均为neoR,长度为816bp。Figure 8 is the electrophoresis image of the positive amplification verification of the neomycin resistance gene neoR in pPMPT-neoR; in the figure, M 7 is DL5,000 DNA Maker (Dalian Bao Biology), 12 and 13 are both neoR, and the length is 816bp.
图9为噬夏孢欧文氏菌中crtZ基因扩增电泳图;图中M8为DL5,000DNA Maker(大连宝生物),14和15均为crtZ基因,长度为528bp。Figure 9 is the amplified electrophoresis image of the crtZ gene in Erwinia erdophila; in the figure, M 8 is DL5,000 DNA Maker (Dalian Baobiology), 14 and 15 are both crtZ genes, and the length is 528bp.
图10为pPMPT-neoR-crtZ中crtZ基因的连接扩增验证电泳图;图中M9为DL5,000DNA Maker(大连宝生物),16为crtZ基因,长度为528bp。Figure 10 is the electrophoresis diagram of the ligation amplification verification of the crtZ gene in pPMPT- neoR -crtZ; in the figure, M9 is DL5,000DNA Maker (Dalian Bao Biology), and 16 is the crtZ gene, with a length of 528bp.
图11为用验证引物扩增pPMPT-neoR-crtZ中的正向连接片段的扩增验证图;图中M10为DL5,000DNA Maker(大连宝生物),17、18和19均为正向连接,长度为1971bp。Figure 11 is the amplification verification diagram of the forward connection fragment in pPMPT-neoR-crtZ amplified with verification primers; M 10 in the figure is DL5,000DNA Maker (Dalian Baobiology), and 17, 18 and 19 are all forward connections , with a length of 1971bp.
图12为转化后DNA扩增验证电泳图;图中M11为DL5,000DNA Maker(大连宝生物),20为阳性转化,长度为1971bp。Figure 12 is the electrophoresis image of post-transformation DNA amplification verification; in the figure, M 11 is DL5,000 DNA Maker (Dalian Bao Biology), 20 is positive transformation, and the length is 1971bp.
图13为玉米黄质标准品高效液相色谱图。Figure 13 is a high performance liquid chromatogram of zeaxanthin standard substance.
图14为玉米黄质待测样品高效液相色谱图。Figure 14 is a high performance liquid chromatogram of a sample of zeaxanthin to be tested.
图15为双基因共表达重组载体的构建流程图。Fig. 15 is a flow chart of the construction of a double-gene co-expression recombinant vector.
具体实施方式Detailed ways
下面实施例用于进一步详细说明本发明,但不以任何形式限制本发明。The following examples are used to further describe the present invention in detail, but do not limit the present invention in any form.
本发明中的专业术语:Technical terms in the present invention:
载体:指用于将外源DNA导入并根据需要在细胞中增殖所述外源DNA的DNA分子(也见Rompp Lexikon chemie CD ROM2.0版本,Stuttgart/New York:Georg Thieme Verlag1999中的“载体”)在本申请中也意指包括质粒、粘粒等相同用途的分子。Vector: refers to a DNA molecule used to introduce foreign DNA and, if desired, propagate said foreign DNA in cells (see also "Vector" in Rompp Lexikon chemie CD ROM version 2.0, Stuttgart/New York: Georg Thieme Verlag 1999 ) in the present application is also meant to include plasmids, cosmids and other molecules of the same purpose.
双元Ti载体:指含有两个T-DNA独立区域并能在大肠杆菌和农杆菌中复制的穿梭质粒。Binary Ti vector: refers to a shuttle plasmid that contains two independent regions of T-DNA and can replicate in Escherichia coli and Agrobacterium.
表达:是指转移从DNA到RNA到基因产物(这里优指类胡萝卜素)的遗传信息。Expression: Refers to the transfer of genetic information from DNA to RNA to gene products (here preferably carotenoids).
遗传信息:优指导入三孢布拉霉并导致三孢布拉霉遗传修饰的核酸,即,列如导致与起始生物相比增高或降低酶活性的核酸。Genetic information: Nucleic acids that are preferably introduced into B. trispora and lead to genetic modification of B. trispora, ie, listed such as those that result in increased or decreased enzyme activity compared to the starting organism.
野生型:指相应的未经遗传修饰的三孢布拉霉起始生物。Wild type: Refers to the corresponding non-genetically modified B. trispora starting organism.
生物:是指三孢布拉霉起始生物(野生型)和三孢布拉霉的经遗传修饰生物或两者兼指。插入:是指将外源核酸加入到载体中。Organism: Refers to the starting organism (wild type) of B. trispora, the genetically modified organism of B. trispora, or both. Insertion: Refers to the addition of exogenous nucleic acid into a vector.
反式失活:指反式失活主要是由于拥有同源序列的沉默位点和其它位点的DNA的相互作用而引起的基因沉默,Vaucheret等的研究表明:启动子区域只要有90bp的序列同源,即可使两个基因间产生反式失活。Trans-inactivation: Trans-inactivation is mainly due to the gene silencing caused by the interaction of the silencing site with homologous sequences and the DNA of other sites. The research of Vaucheret et al. shows that the promoter region only needs 90 bp sequence Homologous, can make trans-inactivation between two genes.
整合:指两个非同源基因连接起来,如加入到载体中的外源片段随机插入到受体的基因组中。Integration: refers to the connection of two non-homologous genes, such as the random insertion of foreign fragments added to the vector into the recipient's genome.
实施例1构建双基因共表达载体Example 1 Construction of double-gene co-expression vector
(1)人工合成基因表达框序列syn:终止子序列(Ter)—多克隆位点(MCS)—双向启动子序列PCarB—TA克隆制备序列—终止子序列(Ter),合成该序列时上游添加SalⅠ酶切位点,下游添加HindⅢ和SalⅠ酶切位点。(1) Synthetic gene expression cassette sequence syn: terminator sequence (Ter) - multiple cloning site (MCS) - bidirectional promoter sequence PCarB - TA clone preparation sequence - terminator sequence (Ter), which is added upstream when synthesizing the sequence SalⅠ restriction site, and HindⅢ and SalⅠ restriction sites are added downstream.
其始末两个终止子(Ter)序列均来自构巢曲霉中的trpC terminator,在丝状真菌和植物中具有终止功能,其大小均为559bp,位于序列syn中的始端和末端。在最终构建好的载体序列SEQ ID NO:3中的信息为:Both the beginning and the end of the terminator (Ter) sequences are from trpC terminator in Aspergillus nidulans, which have termination function in filamentous fungi and plants, both of which are 559bp in size, located at the beginning and end of the sequence syn. The information in the final constructed vector sequence SEQ ID NO:3 is:
Ter 9034-9592 559 misc featureTer 9034-9592 559 misc feature
Ter 10274-10832 559 misc featureTer 10274-10832 559 misc feature
其多克隆位点(MCS)所含有的限制性内切酶依次为XbaⅠ,BstEⅡ,SacⅠ,KpnⅠ,SmaⅠ,MfeⅠ,BglⅡ,可通过酶切连接的方式根据需要加入要表达的片段,由于前后两端含有相应的启动子和终止子,故若插入为正向则可直接表达;其大小为43bp,在序列syn中的第560位到第602位,在最终构建好的载体中序列信息为:The restriction endonucleases contained in its multiple cloning site (MCS) are XbaI, BstEII, SacI, KpnI, SmaI, MfeI, BglII in sequence, and the fragments to be expressed can be added according to the needs by enzyme cutting and ligation. The end contains the corresponding promoter and terminator, so if the insertion is in the forward direction, it can be directly expressed; its size is 43bp, and it is from the 560th to the 602nd in the sequence syn. The sequence information in the final constructed vector is:
MCS 9593-9635 43 misc featureMCS 9593-9635 43 misc feature
其双向启动子(PCarB)序列来源为三孢布拉霉中启动八氢番茄红素脱氢酶基因(carB)和番茄红素环化酶基因(carRA)的启动子序列。该启动子具有双向启动功能,可启动其上游和下游基因序列的表达,其分子量大小为610bp,在序列syn中的第603位到第1212位,在最终构建好的载体中序列信息:The source of its bidirectional promoter (PCarB) sequence is the promoter sequence of phytoene dehydrogenase gene (carB) and lycopene cyclase gene (carRA) in B. trispora. The promoter has a bidirectional start function and can start the expression of its upstream and downstream gene sequences. Its molecular weight is 610bp, and it is from the 603rd to the 1212th position in the sequence syn. The sequence information in the final constructed vector is as follows:
双向启动子PCarB 9636-10245 610 misc featureBidirectional promoter PCarB 9636-10245 610 misc feature
其TA克隆制备序列,本载体中TA克隆的制备时采用酶切的方式直接制备,该序列中包括两个AhdⅠ酶切位点,两个AhdⅠ位点之间引入SpeⅠ酶切位点,其引入SpeⅠ酶切位点的好处:①经SpeⅠ酶切后可以防止载体中的AhdⅠ位点不完全酶切造成的环化。②两个AhdⅠ酶切位点之间,提供保护碱基,便于AhdⅠ的酶切,从而形成效率高的T末端。质粒经AhdⅠ酶切后可以产生T末端,可将带有polyA的PCR产物直接加入,其分子量大小为28bp,在基因syn中的第1213位到1240位,在最终构建好的载体中序列信息:Its TA clone preparation sequence, the preparation of the TA clone in this vector is directly prepared by enzyme digestion, the sequence includes two AhdI restriction sites, and a SpeI restriction site is introduced between the two AhdI sites. Benefits of the SpeI enzyme cutting site: ① SpeI digestion can prevent circularization caused by incomplete digestion of the AhdI site in the vector. ②A protective base is provided between the two AhdⅠ restriction sites to facilitate the digestion of AhdⅠ, thereby forming a highly efficient T-terminal. The plasmid can be digested with AhdI to produce a T-terminal, and the PCR product with polyA can be added directly. Its molecular weight is 28bp, and it is located at the 1213th to 1240th position in the gene syn. The sequence information in the final constructed vector is as follows:
TA克隆位点 10246-10273 28 misc featureTA cloning site 10246-10273 28 misc feature
将以上碱基片段人工合成序列syn,本发明中该人工片段由金唯智生物科技有限公司合成,且由pMD19-T载体携带,即质粒pMD19-T-syn。The above base fragment is artificially synthesized into the sequence syn. In the present invention, the artificial fragment is synthesized by Jinweizhi Biotechnology Co., Ltd. and carried by the pMD19-T vector, namely the plasmid pMD19-T-syn.
将合成的质粒pMD19-T-syn用SalⅠ酶切后,合成序列酶切回收检测图谱如图1所示。After the synthesized plasmid pMD19-T-syn was digested with SalI, the detection map of the synthesis sequence digested and recovered is shown in Fig. 1 .
(2)以构建好的Ti载体pATZ扩增得到潮霉素抗性基因:设计引物(F1,R1)扩增含有潮霉素的表达盒,潮霉素引物分别含有酶切位点BssHⅡ和酶切位点SalⅠ,扩增出的大小为2120bp的潮霉素抗性基因hygR,电泳图谱如图2所示,序列见SEQ ID NO:2。(2) Amplify the hygromycin resistance gene by using the constructed Ti vector pATZ: design primers (F1, R1) to amplify the expression cassette containing hygromycin, and the hygromycin primers contain the restriction site BssHII and enzyme The hygromycin resistance gene hygR with a size of 2120 bp was amplified by cutting site SalI. The electrophoretic pattern is shown in FIG. 2 , and the sequence is shown in SEQ ID NO:2.
其中Ti载体pATZ构建方法见《丝状真菌转化载体的改进》(李继刚.2013年)一文记载。Among them, the construction method of the Ti vector pATZ is described in the article "Improvement of Transformation Vectors for Filamentous Fungi" (Li Jigang. 2013).
设计引物序列为:The primer sequences were designed as:
F1:GTCGACGTCTTCTACTATAACTTCCTCF1: GTCGACGTCTTCTACTATAACTTCCTC
R1:GCGCGCTTTCTTCCTAATGGAGATR1: GCGCGCTTTCTTCCTAATGGAGAT
潮霉素抗性基因(hygR)扩增体系如下:The hygromycin resistance gene (hygR) amplification system is as follows:
扩增条件:94℃预变性5min;94℃变性30s;57℃退火30s;72℃延伸3min,30个循环;72℃后延伸5min。PCR产物用1.5%的琼脂糖凝胶电泳检测。扩增出的产物包含TtrpC、HygR、PtrpC,其序列见SEQ ID NO:2。Amplification conditions: pre-denaturation at 94°C for 5 min; denaturation at 94°C for 30 s; annealing at 57°C for 30 s; extension at 72°C for 3 min, 30 cycles; extension at 72°C for 5 min. PCR products were detected by 1.5% agarose gel electrophoresis. The amplified product contains TtrpC, HygR and PtrpC, the sequence of which is shown in SEQ ID NO:2.
该段序列在最终构建好的载体中的序列信息为:The sequence information of this sequence in the final constructed vector is:
TtrpC 6908-7466 559 misc featureTtrpC 6908-7466 559 misc feature
HygR 7641-8666 1026 misc featureHygR 7641-8666 1026 misc feature
/gene =aph(4)-Ia/gene = aph(4)-Ia
/product =aminoglycoside phosphotransferase from E.Coli/product=aminoglycoside phosphotransferase from E.Coli
/note =confers resistance to hygR romycin/note = confers resistance to hygR romycin
/translation/translation
=MKKPELTATSVEKFLIEKFDSVSDLMQLSEGEESRAFSFDVGGRGYVLRVNSCADGFYKDRYVYRHFASAALPIPEVLDIGEFSESLTYCISRRAQGVTLQDLPETELPAVLQPVAEAMDAIAAADLSQTSGFGPFGPQGIGQYTTWRDFICAIADPHVYHWQTVMDDTVSASVAQALDELMLWAEDCPEVRHLVHADFGSNNVLTDNGRITAVIDWSEAMFGDSQYEVANIFFWRPWLACMEQQTRYFERRHPELAGSPRLRAYMLRIGLDQLYQSLVDGNFDDAAWAQGRCDAIVRSGAGTVGRTQIARRSAAVWTDGCVEVLADSGNRRPSTRPRAKE=MKKPELTATSVEKFLIEKFDSVSDLMQLSEGEESRAFSFDVGGRGYVLRVNSCADGFYKDRYVYRHFASAALPIPEVLDIGEFSESLTYCISRRAQGVTLQDLPETELPAVLQPVAEAMDAIAAADLSQTSGFGPFGPQGIGQYTTWRDFICAIADPHVYHWQTVMDDTVSASVAQALDELMLWAEDCPEVRHLVHADFGSNNVLTDNGRITAVIDWSEAMFGDSQYEVANIFFWRPWLACMEQQTRYFERRHPELAGSPRLRAYMLRIGLDQLYQSLVDGNFDDAAWAQGRCDAIVRSGAGTVGRTQIARRSAAVWTDGCVEVLADSGNRRPSTRPRAKE
341amino acids=38.0kDa341amino acids=38.0kDa
PtrpC 8671-9028 358 misc featurePtrpC 8671-9028 358 misc feature
(3)将步骤(2)中扩增的潮霉素抗性基因hygR与pMD-19-T(simple)载体在16℃恒温金属浴中连接过夜;筛选阳性克隆。用M13引物扩增验证阳性克隆子,得pMD19-T-hygR,其扩增电泳图谱如图3所示。(3) Ligate the hygromycin resistance gene hygR amplified in step (2) with the pMD-19-T (simple) vector in a constant temperature metal bath at 16°C overnight; screen positive clones. The positive clones were amplified with M13 primers to obtain pMD19-T-hygR, and its amplified electrophoresis pattern is shown in Figure 3 .
(4)将步骤(3)中筛选的阳性克隆质粒pMD19-T-hygR和步骤(1)中的质粒pMD19-T-syn分别以SalⅠ限制性内切酶进行酶切,回收酶切产物pMD19-T-hygR和syn两片段,再将pMD19-T-hygR和syn在16℃下连接过夜;并设计引物(F3,R3)扩增验证选择正向连接的克隆,如图4所示,得pMD19-T-hygR-syn。(4) Digest the positive cloned plasmid pMD19-T-hygR screened in step (3) and the plasmid pMD19-T-syn in step (1) respectively with SalI restriction endonuclease, and recover the digested product pMD19- Two fragments of T-hygR and syn, and pMD19-T-hygR and syn were ligated overnight at 16°C; and primers (F3, R3) were designed to amplify and verify that the positively connected clone was selected, as shown in Figure 4, to obtain pMD19 -T-hygR-syn.
引物序列为:The primer sequences are:
F3:GCACTCTTTGCTGCTTGGAF3: GCACTCTTTGCTGCTTGGA
R3:GCTACTTACACACAGGACATCR3: GCTACTTACACACAGGACATC
正向连接扩增体系如下:The forward connection amplification system is as follows:
扩增条件:94℃预变性5min;94℃变性30s;57℃退火30s;72℃延伸4min,30个循环;72℃后延伸5min。PCR产物用1.5%的琼脂糖凝胶电泳检测。Amplification conditions: pre-denaturation at 94°C for 5 min; denaturation at 94°C for 30 s; annealing at 57°C for 30 s; extension at 72°C for 4 min, 30 cycles; extension at 72°C for 5 min. PCR products were detected by 1.5% agarose gel electrophoresis.
(5)将pATZ质粒和步骤(4)得到的正向连接的克隆pMD19-T-hygR-syn分别用BssHⅡ和HindⅢ双酶切,酶切产物回收hygR-syn、质粒pATZ酶切后剩余的含有T-DNA的部分,将回收的两个片段16℃连接过夜,用步骤(4)中的引物(F3、R3)进行扩增验证是否正确连接,筛选阳性克隆,得到阳性克隆质粒pATZ-hygR-syn即为双基因共表达重组载体pPMPT。其筛选阳性克隆的扩增程序如步骤(4),扩增电泳结果如图5所示。(5) The pATZ plasmid and the forward-connected clone pMD19-T-hygR-syn obtained in step (4) were digested with BssHII and HindIII, respectively, and the digested product was recovered hygR-syn, and the rest of the plasmid pATZ was digested with For the part of T-DNA, connect the recovered two fragments overnight at 16°C, amplify with the primers (F3, R3) in step (4) to verify whether the connection is correct, screen positive clones, and obtain the positive clone plasmid pATZ-hygR- syn is the double gene co-expression recombinant vector pPMPT. The amplification procedure for screening positive clones is as in step (4), and the amplification electrophoresis results are shown in FIG. 5 .
实施例2重组载体的应用Application of embodiment 2 recombinant vector
本实施例中将实施例1中构建的载体pPMPT插入两个基因:基因neoR(见SEQ IDNO:4)和基因crtZ(见SEQ ID NO:5);转化后进行验证是否转化成功并可以稳定遗传,可以将其在新霉素抗性(neoR)板上进行4-5次传代,挑取最终抗性板上生长的三孢布拉霉进行DNA提取,扩增质粒pPMPT中含有的潮霉素抗性基因以及插入的neoR基因和crtZ基因进行验证。In this embodiment, the vector pPMPT constructed in Example 1 is inserted into two genes: gene neoR (see SEQ ID NO: 4) and gene crtZ (see SEQ ID NO: 5); after transformation, verify whether the transformation is successful and stable inheritance , it can be subcultured for 4-5 times on the neomycin resistance (neoR) plate, pick the B. trispora grown on the final resistance plate for DNA extraction, and amplify the hygromycin contained in the plasmid pPMPT The resistance gene and the inserted neoR gene and crtZ gene were verified.
分别在pet-28a质粒和噬夏孢欧文氏菌中扩增一个带有自主复制子但缺失自身启动子的新霉素抗性基因neoR和crtZ基因,crtZ基因能表达β-胡萝卜素羟化酶,将三孢布拉霉的终产物β-胡萝卜素转变为玉米黄质,将这两段基因插入到已构建质粒pPMPT中,得到pPMPT-neoR-crtZ质粒,通过农杆菌介导法转化,对再新霉素抗性平板上生长的三孢布拉霉进行色素的提取,经HPLC检测,发现表达玉米黄质,即得到了抗新霉素且表达玉米黄质的三孢布拉霉菌株,并表现稳定,可通过孢子无性繁殖稳定遗传下去,证明了该质粒的功能。A neomycin resistance gene neoR and crtZ gene with an autonomous replicator but lacking its own promoter were amplified in the pet-28a plasmid and Erwinia erdophila, respectively, and the crtZ gene can express β-carotene hydroxylase , the final product β-carotene of B. trispora was converted into zeaxanthin, and these two genes were inserted into the constructed plasmid pPMPT to obtain the pPMPT-neoR-crtZ plasmid, which was transformed by Agrobacterium-mediated transformation. The pigment was extracted from the B. trispora grown on the neomycin-resistant plate, and detected by HPLC, it was found that zeaxanthin was expressed, and a neomycin-resistant and zeaxanthin-expressed B. trispora strain was obtained. And the performance is stable, and can be stably inherited through spore asexual reproduction, which proves the function of the plasmid.
具体过程如下:The specific process is as follows:
(1)抑制农杆菌生长所需头孢噻肟钠的浓度确定(1) Determination of the concentration of cefotaxime sodium required to inhibit the growth of Agrobacterium
吸取100μL培养过夜的农杆菌,涂布在浓度梯度为0、50、100、150、200μg/mL的头孢噻肟钠抗性平板上,每个梯度做三个平行,培养三天发现,随头孢噻肟钠浓度的提高,农杆菌生长也变得微弱,当达到50μg/mL时,农杆菌基本不长。Draw 100 μL of Agrobacterium cultured overnight, spread it on the cefotaxime sodium-resistant plate with concentration gradients of 0, 50, 100, 150, and 200 μg/mL, do three parallels for each gradient, and cultivate for three days to find out, with cephalosporin As the concentration of sodium thioxime increased, the growth of Agrobacterium also became weak, and when it reached 50μg/mL, the Agrobacterium basically did not grow.
(2)三孢布拉霉对新霉素和头孢噻肟钠抗性筛选浓度的确定(2) Determination of the screening concentration for B. trispora resistance to neomycin and cefotaxime sodium
将三孢布拉霉制成孢子悬液,取200μL涂布在不同浓度梯度的新霉素和头孢噻肟钠抗性平板上,新霉素和头孢噻肟钠浓度梯度均设为0、50、100、150、200μg/mL,观察三孢布拉霉生长状况,发现新霉素浓度达到200μg/mL时,三孢布拉霉彻底生长,头孢噻肟钠浓度达到200μg/mL时,仍生长良好,所以确定的最终的新霉素筛选浓度为200μg/mL,头孢噻肟钠浓度为100μg/mL。Make a spore suspension of B. trispora, and spread 200 μL on neomycin and cefotaxime sodium-resistant plates with different concentration gradients. , 100, 150, 200 μg/mL, observed the growth of B. trispora, and found that when the concentration of neomycin reached 200 μg/mL, B. trispora grew completely, and when the concentration of cefotaxime sodium reached 200 μg/mL, it still grew Good, so the determined final neomycin screening concentration is 200 μg/mL and cefotaxime sodium concentration is 100 μg/mL.
(3)构建pPMPT-neoR质粒(3) Construction of pPMPT-neoR plasmid
首先,从pet-28a中扩增新霉素抗性基因,扩增图谱如图6所示。First, the neomycin resistance gene was amplified from pet-28a, and the amplification map is shown in FIG. 6 .
设计引物时分别在上游和下游两端加上限制性酶切位点BglⅡ和XbaⅠ,扩增引物序列为:When designing primers, add restriction enzyme sites BglII and XbaI to the upstream and downstream ends respectively, and the sequence of the amplification primers is:
F4:AGATCTATGAGCCATATTCAACGGGF4: AGATCTATGAGCCATATTCAACGGG
R4:TCTAGATTAGAAAAACTCATCGAGCAR4: TCTAGATTAGAAAAACTCATCGAGCA
新霉素抗性基因(neoR)扩增体系如下:The neomycin resistance gene (neoR) amplification system is as follows:
扩增条件:94℃预变性5min;94℃变性30s;58℃退火30s;72℃延伸1min,30个循环;72℃后延伸5min。PCR产物用1.5%的琼脂糖凝胶电泳检测。Amplification conditions: pre-denaturation at 94°C for 5 min; denaturation at 94°C for 30 s; annealing at 58°C for 30 s; extension at 72°C for 1 min, 30 cycles; extension at 72°C for 5 min. PCR products were detected by 1.5% agarose gel electrophoresis.
将扩增的新霉素抗性基因按一定比例和T载体连接过夜,转化大肠杆菌,挑取克隆子进行验证。The amplified neomycin resistance gene was connected to the T vector overnight at a certain ratio, transformed into Escherichia coli, and clones were picked for verification.
对阳性克隆子进行培养过夜,提取质粒,做酶切,分别将该质粒和pPMPT质粒用bglⅡ和XbaⅠ进行双酶切。酶切回收图谱如图7所示。The positive clones were cultured overnight, the plasmids were extracted and digested, and the plasmids and pPMPT plasmids were digested with bglII and XbaI respectively. The enzyme digestion recovery pattern is shown in Figure 7.
按照一定比例将回收产物进行连接过夜,用氯霉素作为抗性筛选标记,挑取阳性克隆子,用新霉素引物进行扩增验证。According to a certain ratio, the recovered products were ligated overnight, and chloramphenicol was used as a resistance selection marker to pick positive clones, and neomycin primers were used for amplification verification.
新霉素抗性基因(neoR)扩增体系如下:The neomycin resistance gene (neoR) amplification system is as follows:
扩增条件:94℃预变性5min;94℃变性30s;57℃~60℃退火30s;72℃延伸1min,30个循环;72℃后延伸5min。PCR产物用1.5%的琼脂糖凝胶电泳检测。扩增图谱如图8所示。Amplification conditions: pre-denaturation at 94°C for 5 min; denaturation at 94°C for 30 s; annealing at 57°C to 60°C for 30 s; extension at 72°C for 1 min, 30 cycles; extension at 72°C for 5 min. PCR products were detected by 1.5% agarose gel electrophoresis. The amplification map is shown in Figure 8.
(4)构建pPMPT-neoR-crtZ质粒(4) Construction of pPMPT-neoR-crtZ plasmid
直接扩增crtZ序列,设计引物序列如下:To directly amplify the crtZ sequence, the designed primer sequences are as follows:
F5:5’-AAGCTTATGTTGTGGATTTGG-3’F5: 5'-AAGCTTATGTTGTGGATTTGG-3'
R5:5’-AAGCTTAGGATCCTTACTTCCCG-3’R5: 5'-AAGCTTAGGATCCTTACTTCCCG-3'
crtZ基因的扩增体系如下:The amplification system of the crtZ gene is as follows:
扩增条件:94℃预变性5min;94℃变性30s;57℃~60℃退火30s;72℃延伸1min,30个循环;72℃后延伸5min。PCR产物用1.5%的琼脂糖凝胶电泳检测。扩增图谱如图9所示。Amplification conditions: pre-denaturation at 94°C for 5 min; denaturation at 94°C for 30 s; annealing at 57°C to 60°C for 30 s; extension at 72°C for 1 min, 30 cycles; extension at 72°C for 5 min. PCR products were detected by 1.5% agarose gel electrophoresis. The amplification map is shown in Figure 9.
对(3)中所构建的pPMPT-neoR质粒用AhdⅠ酶切,使其形成线性T末端,直接与crtZ基因的扩增产物连接过夜,转化大肠杆菌,用氯霉素作为抗性筛选标记,得到pPMPT-neoR-crtZ质粒,用引物(F5和R5)扩增检测筛选阳性克隆子。The pPMPT-neoR plasmid constructed in (3) was digested with AhdI to form a linear T-terminus, directly connected to the amplified product of the crtZ gene overnight, transformed into Escherichia coli, and chloramphenicol was used as a resistance selection marker to obtain The pPMPT-neoR-crtZ plasmid was amplified with primers (F5 and R5) to detect positive clones.
crtZ基因(crtZ)扩增体系和扩增程序如上。其检测图谱如图10所示。The crtZ gene (crtZ) amplification system and amplification procedure are as above. Its detection spectrum is shown in Figure 10.
用neoR下游引物和crtZ基因的下游引物,对阳性克隆子进行扩增,验证和筛选crtZ基因连接正反向。扩增检测图谱如图11所示。Use the neoR downstream primer and the crtZ gene downstream primer to amplify the positive clones, verify and screen the forward and reverse connections of the crtZ gene. The amplification detection map is shown in Figure 11.
正向连接扩增体系如下:The forward connection amplification system is as follows:
扩增条件:94℃预变性5min;94℃变性30s;57℃~60℃退火30s;72℃延伸2min,30个循环;72℃后延伸5min。PCR产物用1.5%的琼脂糖凝胶电泳检测。Amplification conditions: pre-denaturation at 94°C for 5 minutes; denaturation at 94°C for 30 seconds; annealing at 57°C to 60°C for 30 seconds; extension at 72°C for 2 minutes, 30 cycles; extension at 72°C for 5 minutes. PCR products were detected by 1.5% agarose gel electrophoresis.
将构建好的pPMPT-neoR-crtZ质粒转化至农杆菌,用农杆菌介导的方法转化三孢布拉霉,在转化时用到的抗性筛选标记是新霉素抗性筛选标记,挑取在抗性平板上生长的阳性转化子,进行DNA的提取,扩增新霉素抗性基因,检测是否转化成功。Transform the constructed pPMPT-neoR-crtZ plasmid into Agrobacterium, and use the Agrobacterium-mediated method to transform B. trispora. The resistance selection marker used in the transformation is a neomycin resistance selection marker. For the positive transformant grown on the resistance plate, the DNA was extracted, and the neomycin resistance gene was amplified to detect whether the transformation was successful.
扩增检测图谱如图12所示。The amplification detection map is shown in Figure 12.
对转化后的三孢布拉霉进行发酵,发酵大概7天,对发酵产物进行冷冻干燥、研磨、抽提等一系列处理,得到所要的色素,经HPLC检测,发现了玉米黄质的存在。The transformed B. trispora was fermented for about 7 days, and the fermentation product was subjected to a series of treatments such as freeze-drying, grinding, and extraction to obtain the desired pigment, and the presence of zeaxanthin was found through HPLC detection.
玉米黄质标准品及待测样品高效液相色谱图如图13和图14所示。The HPLC chromatograms of zeaxanthin standard substance and samples to be tested are shown in Figure 13 and Figure 14.
以上所插入的neoR和crtZ基因分别都可以替换成任意想要表达的基因,来得到目的产物,从而来实现该质粒的功能。由此可见,本发明可以同时表达两个以上的基因,且无需添加启动子以及进行多次外源基因的整合,操作工艺简单,基因表达量一致,未发生反义失活等问题,遗传较为稳定。The neoR and crtZ genes inserted above can be replaced with any desired gene to obtain the target product, thereby realizing the function of the plasmid. It can be seen that the present invention can express two or more genes at the same time without adding a promoter and integrating multiple exogenous genes. Stablize.
本发明中的TA克隆位点处在改造不同的载体时两个AhdⅠ酶切位点选择性的同时换成XcmⅠ,BciⅥ,BmrⅠ,HphⅠ,Hpy188Ⅰ,HpyCH4Ⅲ,MboⅡ,MnlⅠ酶切位点均可制备T末端,来用于PCR产物的直接连接。The TA cloning site in the present invention can be prepared by selectively replacing the two AhdⅠ restriction sites with XcmⅠ, BciⅥ, BmrⅠ, HphⅠ, Hpy188Ⅰ, HpyCH4Ⅲ, MboⅡ, and MnlⅠ restriction sites when transforming different vectors T-terminus for direct ligation of PCR products.
SEQUENCE LISTING SEQUENCE LISTING
<110> 河北大学<110> Hebei University
<120> 一种双基因共表达重组载体及其构建方法和应用<120> A Double-gene Co-expression Recombinant Vector and Its Construction Method and Application
<130><130>
<160> 5<160> 5
<170> PatentIn version 3.3<170> PatentIn version 3.3
<210> 1<210> 1
<211> 1799<211> 1799
<212> DNA<212>DNA
<213> 基因表达框序列syn<213> gene expression cassette sequence syn
<400> 1<400> 1
aaagaaggat tacctctaaa caagtgtacc tgtgcattct gggtaaacga ctcataggag 60aaagaaggat tacctctaaa caagtgtacc tgtgcattct gggtaaacga ctcataggag 60
agttgtaaaa aagtttcggc cggcgtattg ggtgttacgg agcattcact aggcaaccat 120agttgtaaaa aagtttcggc cggcgtattg ggtgttacgg agcattcact aggcaaccat 120
ggttactatt gtataccatc ttagtaggaa tgatttcgag gtttatacct acgatgaatg 180ggttactatt gtataccatc ttagtaggaa tgatttcgag gtttatacct acgatgaatg 180
tgtgtcctgt aggcttgaga gttcaaggaa gaaacatgca attatctttg cgaacccagg 240tgtgtcctgt aggcttgaga gttcaaggaa gaaacatgca attatctttg cgaacccagg 240
gctggtgacg gaattttcat agtcaagcta tcagagtaaa gaagaggagc atgtcaaagt 300gctggtgacg gaattttcat agtcaagcta tcagagtaaa gaagaggagc atgtcaaagt 300
acaattagag acaaatatat agtcgcgtgg agccaagagc ggattcctca gtctcgtagg 360acaattagag acaaatatat agtcgcgtgg agccaagagc ggattcctca gtctcgtagg 360
tctcttgacg accgttgatc tgcttgatct cgtctcccga aaatgaaaat agctctgcta 420tctcttgacg accgttgatc tgcttgatct cgtctcccga aaatgaaaat agctctgcta 420
agctattctt ctcttcgccg gagcctgaag gcgttactag gttgcagtca atgcattaat 480agctattctt ctcttcgccg gagcctgaag gcgttactag gttgcagtca atgcattaat 480
gcattgcaga tgagctgtat ctggaagagg taaacccgaa aacgcgtttt attcttgttg 540gcattgcaga tgagctgtat ctggaagagg taaacccgaa aacgcgtttt attcttgttg 540
acatggagct attaaatcat ctagaggtca ccgagctcgg tacccccggg caattgagat 600acatggagct attaaatcat ctagaggtca ccgagctcgg taccccccggg caattgagat 600
ctgagattaa aatagataag gaaaagaaag tgaaaagaaa ttcggaagca tggcacattc 660ctgagattaa aatagataag gaaaagaaag tgaaaagaaa ttcggaagca tggcacattc 660
ttctttttat aaatacatgc ctgactttct ttttccatcg atatgatata tgcatatgat 720ttctttttat aaatacatgc ctgactttct ttttccatcg atatgatata tgcatatgat 720
agatatacaa gcaatcttct tcaaggagtt tgaaattttg tcctccagga gcaaaaaaaa 780agatatacaa gcaatcttct tcaaggagtt tgaaattttg tcctccagga gcaaaaaaaa 780
gttttttttt atacatgttt gtacacaaga atagttacca atttgctttg gtcttacgtg 840gttttttttt atacatgttt gtacacaaga atagttacca atttgctttg gtcttacgtg 840
ctgcaagttt atatcgtttt caatttcttt gtctttacat tttctttgtc ctttatcttt 900ctgcaagttt atatcgtttt caatttcttt gtctttacat tttctttgtc ctttatcttt 900
cctcatttag tctttgggag aattaggaaa agggagcgga aaggtaagaa atgcttgcgt 960cctcatttag tctttgggag aattaggaaa agggagcgga aaggtaagaa atgcttgcgt 960
attttactaa ttcggcaaac atccaatttg gcaaacagca gcctgtgcaa cgctctcgag 1020attttactaa ttcggcaaac atccaatttg gcaaacagca gcctgtgcaa cgctctcgag 1020
atgacagtat ctttgattac actctaaatc tcgatgaccc gaccaaaaag agcgaacaaa 1080atgacagtat ctttgattac actctaaatc tcgatgaccc gaccaaaaag agcgaacaaa 1080
gaaataatct tgtgcattcg aatatgatgg aagatttttt cccccttatt ctaaatgttg 1140gaaataatct tgtgcattcg aatatgatgg aagatttttt cccccttatt ctaaatgttg 1140
acatagcgtg tatgttatat aaacaaaaag aaattgtaca aactttcttt tcttctcttt 1200acatagcgtg tatgttatat aaacaaaaag aaattgtaca aactttcttt tcttctcttt 1200
ttattttatc tcgactctgg gtcactagtg acccagagtc actaaattat cgaggtacag 1260ttattttc tcgactctgg gtcactagtg accccagagtc actaaattat cgaggtacag 1260
ttgttcttat tttgcgcaaa agcccaaatg gagaaggtct atgtcgagta gacgttacgt 1320ttgttcttat tttgcgcaaa agcccaaatg gagaaggtct atgtcgagta gacgttacgt 1320
aattacgtaa ctgacgttgg atcattgcgg aagtccgagg ccgcttctct tcttatcgaa 1380aattacgtaa ctgacgttgg atcattgcgg aagtccgagg ccgcttctct tcttatcgaa 1380
tcgtctcgat aaaagtaaaa gccctctgct ctagttcgtc tagttgccag cagttctctg 1440tcgtctcgat aaaagtaaaa gccctctgct ctagttcgtc tagttgccag cagttctctg 1440
gatgctctga ctccttaggc gagaaccgag gtgcgctgat atataaacag agattaacat 1500gatgctctga ctccttaggc gagaaccgag gtgcgctgat atataaacag agattaacat 1500
gaaactgtac gaggagaaga aatgagacta tcgaactgat acttttaagg cagtggtcgg 1560gaaactgtac gaggagaaga aatgagacta tcgaactgat acttttaagg cagtggtcgg 1560
gacccaagcg tttctattaa cgtacaaaga aggaacttga gagttcggat gtcctgtgtg 1620gacccaagcg tttctattaa cgtacaaaga aggaacttga gagttcggat gtcctgtgtg 1620
taagtagcat ccatatttgg agctttagta aggatgattc taccatatgt tatcattggt 1680taagtagcat ccatatttgg agctttagta aggatgattc taccatatgt tatcattggt 1680
accaacggat cacttacgag gcattgtggg ttatgcggcc ggctttgaaa aaatgttgag 1740accaacggat cacttacgag gcattgtggg ttatgcggcc ggctttgaaa aaatgttgag 1740
aggatactca gcaaatgggt cttacgtgtc catgtgaaca aatctccatt aggaagaaa 1799aggatactca gcaaatgggt ccttacgtgtc catgtgaaca aatctccatt aggaagaaa 1799
<210> 2<210> 2
<211> 2120<211> 2120
<212> DNA<212>DNA
<213> 潮霉素抗性基因hygR<213> hygromycin resistance gene hygR
<400> 2<400> 2
cgcgcaaaga aggattacct ctaaacaagt gtacctgtgc attctgggta aacgactcat 60cgcgcaaaga aggattacct ctaaacaagt gtacctgtgc attctgggta aacgactcat 60
aggagagttg taaaaaagtt tcggccggcg tattgggtgt tacggagcat tcactaggca 120aggagagttg taaaaaagtt tcggccggcg tattgggtgt tacggagcat tcactaggca 120
accatggtta ctattgtata ccatcttagt aggaatgatt tcgaggttta tacctacgat 180accatggtta ctattgtata ccatcttagt aggaatgatt tcgaggtta tacctacgat 180
gaatgtgtgt cctgtaggct tgagagttca aggaagaaac atgcaattat ctttgcgaac 240gaatgtgtgt cctgtaggct tgagagttca aggaagaaac atgcaattat ctttgcgaac 240
ccagggctgg tgacggaatt ttcatagtca agctatcaga gtaaagaaga ggagcatgtc 300ccagggctgg tgacggaatt ttcatagtca agctatcaga gtaaagaaga ggagcatgtc 300
aaagtacaat tagagacaaa tatatagtcg cgtggagcca agagcggatt cctcagtctc 360aaagtacaat tagagacaaa tatatagtcg cgtggagcca agagcggatt cctcagtctc 360
gtaggtctct tgacgaccgt tgatctgctt gatctcgtct cccgaaaatg aaaatagctc 420gtaggtctct tgacgaccgt tgatctgctt gatctcgtct cccgaaaatg aaaatagctc 420
tgctaagcta ttcttctctt cgccggagcc tgaaggcgtt actaggttgc agtcaatgca 480tgctaagcta ttcttctctt cgccggagcc tgaaggcgtt actaggttgc agtcaatgca 480
ttaatgcatt gcagatgagc tgtatctgga agaggtaaac ccgaaaacgc gttttattct 540ttaatgcatt gcagatgagc tgtatctgga agaggtaaac ccgaaaacgc gttttattct 540
tgttgacatg gagctattaa atcactagaa ggcactcttt gctgcttgga caaatgaacg 600tgttgacatg gagctattaa atcactagaa ggcactcttt gctgcttgga caaatgaacg 600
tatcttatcg agatcctgaa caccatttgt ctcaactccg gagctgacat cgacaccaac 660tatcttatcg agatcctgaa caccatttgt ctcaactccg gagctgacat cgacaccaac 660
gatcttatat ccagattcgt caagctgttt gatgatttca gtaacgttaa gtggatccgg 720gatcttatat ccagattcgt caagctgttt gatgatttca gtaacgttaa gtggatccgg 720
tcggcatcta ctctattcct ttgccctcgg acgagtgctg gggcgtcggt ttccactatc 780tcggcatcta ctctattcct ttgccctcgg acgagtgctg gggcgtcggt ttccactatc 780
ggcgagtact tctacacagc catcggtcca gacggccgcg cttctgcggg cgatttgtgt 840ggcgagtact tctacacagc catcggtcca gacggccgcg cttctgcggg cgatttgtgt 840
acgcccgaca gtcccggctc cggatcggac gattgcgtcg catcgaccct gcgcccaagc 900acgcccgaca gtcccggctc cggatcggac gattgcgtcg catcgaccct gcgcccaagc 900
tgcatcatcg aaattgccgt caaccaagct ctgatagagt tggtcaagac caatgcggag 960tgcatcatcg aaattgccgt caaccaagct ctgatagagt tggtcaagac caatgcggag 960
catatacgcc cggagccgcg gcgatcctgc aagctccgga tgcctccgct cgaagtagcg 1020catatacgcc cggagccgcg gcgatcctgc aagctccgga tgcctccgct cgaagtagcg 1020
cgtctgctgc tccatacaag ccaaccacgg cctccagaag aagatgttgg cgacctcgta 1080cgtctgctgc tccatacaag ccaaccacgg cctccagaag aagatgttgg cgacctcgta 1080
ttgggaatcc ccgaacatcg cctcgctcca gtcaatgacc gctgttatgc ggccattgtc 1140ttgggaatcc ccgaacatcg cctcgctcca gtcaatgacc gctgttatgc ggccattgtc 1140
cgtcaggaca ttgttggagc cgaaatccgc gtgcacgagg tgccggactt cggggcagtc 1200cgtcaggaca ttgttggagc cgaaatccgc gtgcacgagg tgccggactt cggggcagtc 1200
ctcggcccaa agcatcagct catcgagagc ctgcgcgacg gacgcactga cggtgtcgtc 1260ctcggcccaa agcatcagct catcgagagc ctgcgcgacg gacgcactga cggtgtcgtc 1260
catcacagtt tgccagtgat acacatgggg atcagcaatc gcgcatatga aatcacgcca 1320catcacagtt tgccagtgat acacatgggg atcagcaatc gcgcatatga aatcacgcca 1320
tgtagtgtat tgaccgattc cttgcggtcc gaatgggccg aacccgctcg tctggctaag 1380tgtagtgtat tgaccgattc cttgcggtcc gaatgggccg aacccgctcg tctggctaag 1380
atcggccgca gcgatcgcat ccatggcctc cgcgaccggc tgcagaacag cgggcagttc 1440atcggccgca gcgatcgcat ccatggcctc cgcgaccggc tgcagaacag cgggcagttc 1440
ggtttcaggc aggtcttgca acgtgacacc ctgtgcacgg cgggagatgc aataggtcag 1500ggtttcaggc aggtcttgca acgtgacacc ctgtgcacgg cgggagatgc aataggtcag 1500
gctctcgctg aattccccaa tgtcaagcac ttccggaatc gggagcgcgg ccgatgcaaa 1560gctctcgctg aattccccaa tgtcaagcac ttccggaatc gggagcgcgg ccgatgcaaa 1560
gtgccgataa acataacgat ctttgtagaa accatcggcg cagctattta cccgcaggac 1620gtgccgataa acataacgat ctttgtagaa accatcggcg cagctattta cccgcaggac 1620
atatccacgc cctcctacat cgaagctgaa agcacgagat tcttcgccct ccgagagctg 1680atatccacgc cctcctacat cgaagctgaa agcacgagat tcttcgccct ccgagagctg 1680
catcaggtcg gagacgctgt cgaacttttc gatcagaaac ttctcgacag acgtcgcggt 1740catcaggtcg gagacgctgt cgaacttttc gatcagaaac ttctcgacag acgtcgcggt 1740
gagttcaggc tttttcatat cgatgcttgg gtagaatagg taagtcagat tgaatctgaa 1800gagttcaggc tttttcatat cgatgcttgg gtagaatagg taagtcagat tgaatctgaa 1800
ataaagggag gaagggcgaa cttaagaagg tatgaccggg tcgttcactt accttgcttg 1860ataaagggag gaagggcgaa cttaagaagg tatgaccggg tcgttcactt accttgcttg 1860
acaaacgcac aagttatcgt gcaccaagca gcagatgata ataatgtcct cgttcctgtc 1920acaaacgcac aagttatcgt gcaccaagca gcagatgata ataatgtcct cgttcctgtc 1920
tgctaataag agtcacactt cgagcgccgc cgctactgct tacaagtggg ctgatctgac 1980tgctaataag agtcacactt cgagcgccgc cgctactgct tacaagtggg ctgatctgac 1980
cagttgccta aatgaaccat cttgtcaaac gacacaaatt ttgtgatccg cctggacgac 2040cagttgccta aatgaaccat cttgtcaaac gacacaaatt ttgtgatccg cctggacgac 2040
taaaccaaaa tagcattgat gtgttgacct ccactagctc cagccaagcc caaaaatgct 2100taaaccaaaa tagcattgat gtgttgacct cactagctc cagccaagcc caaaaatgct 2100
ccttcaatat catcttctgg 2120ccttcaatat catcttctgg 2120
<210> 3<210> 3
<211> 11198<211> 11198
<212> DNA<212> DNA
<213> pPMPT<213> pPMPT
<400> 3<400> 3
agtactttga tccaacccct ccgctgctat agtgcagtcg gcttctgacg ttcagtgcag 60agtactttga tccaacccct ccgctgctat agtgcagtcg gcttctgacg ttcagtgcag 60
ccgtcttctg aaaacgacat gtcgcacaag tcctaagtta cgcgacaggc tgccgccctg 120ccgtcttctg aaaacgacat gtcgcacaag tcctaagtta cgcgacaggc tgccgccctg 120
cccttttcct ggcgttttct tgtcgcgtgt tttagtcgca taaagtagaa tacttgcgac 180cccttttcct ggcgttttct tgtcgcgtgt tttagtcgca taaagtagaa tacttgcgac 180
tagaaccgga gacattacgc catgaacaag agcgccgccg ctggcctgct gggctatgcc 240tagaaccgga gacattacgc catgaacaag agcgccgccg ctggcctgct gggctatgcc 240
cgcgtcagca ccgacgacca ggacttgacc aaccaacggg ccgaactgca cgcggccggc 300cgcgtcagca ccgacgacca ggacttgacc aaccaacggg ccgaactgca cgcggccggc 300
tgcaccaagc tgttttccga gaagatcacc ggcaccaggc gcgaccgccc ggagctggcc 360tgcaccaagc tgttttccga gaagatcacc ggcaccaggc gcgaccgccc ggagctggcc 360
aggatgcttg accacctacg ccctggcgac gttgtgacag tgaccaggct agaccgcctg 420aggatgcttg accacctacg ccctggcgac gttgtgacag tgaccaggct agaccgcctg 420
gcccgcagca cccgcgacct actggacatt gccgagcgca tccaggaggc cggcgcgggc 480gcccgcagca cccgcgacct actggacatt gccgagcgca tccaggaggc cggcgcgggc 480
ctgcgtagcc tggcagagcc gtgggccgac accaccacgc cggccggccg catggtgttg 540ctgcgtagcc tggcagagcc gtgggccgac accaccacgc cggccggccg catggtgttg 540
accgtgttcg ccggcattgc cgagttcgag cgttccctaa tcatcgaccg cacccggagc 600accgtgttcg ccggcattgc cgagttcgag cgttccctaa tcatcgaccg cacccggagc 600
gggcgcgagg ccgccaaggc ccgaggcgtg aagtttggcc cccgccctac cctcaccccg 660gggcgcgagg ccgccaaggc ccgaggcgtg aagtttggcc cccgccctac cctcaccccg 660
gcacagatcg cgcacgcccg cgagctgatc gaccaggaag gccgcaccgt gaaagaggcg 720gcacagatcg cgcacgcccg cgagctgatc gaccaggaag gccgcaccgt gaaagaggcg 720
gctgcactgc ttggcgtgca tcgctcgacc ctgtaccgcg cacttgagcg cagcgaggaa 780gctgcactgc ttggcgtgca tcgctcgacc ctgtaccgcg cacttgagcg cagcgaggaa 780
gtgacgccca ccgaggccag gcggcgcggt gccttccgtg aggacgcatt gaccgaggcc 840gtgacgccca ccgaggccag gcggcgcggt gccttccgtg aggacgcatt gaccgaggcc 840
gacgccctgg cggccgccga gaatgaacgc caagaggaac aagcatgaaa ccgcaccagg 900gacgccctgg cggccgccga gaatgaacgc caagaggaac aagcatgaaa ccgcaccagg 900
acggccagga cgaaccgttt ttcattaccg aagagatcga ggcggagatg atcgcggccg 960acggccagga cgaaccgttt ttcattaccg aagagatcga ggcggagatg atcgcggccg 960
ggtacgtgtt cgagccgccc gcgcacgtct caaccgtgcg gctgcatgaa atcctggccg 1020ggtacgtgtt cgagccgccc gcgcacgtct caaccgtgcg gctgcatgaa atcctggccg 1020
gtttgtctga tgccaagctg gcggcctggc cggccagctt ggccgctgaa gaaaccgagc 1080gtttgtctga tgccaagctg gcggcctggc cggccagctt ggccgctgaa gaaaccgagc 1080
gccgccgtct aaaaaggtga tgtgtatttg agtaaaacag cttgcgtcat gcggtcgctg 1140gccgccgtct aaaaaggtga tgtgtatttg agtaaaacag cttgcgtcat gcggtcgctg 1140
cgtatatgat gcgatgagta aataaacaaa tacgcaaggg gaacgcatga aggttatcgc 1200cgtatatgat gcgatgagta aataaacaaa tacgcaaggg gaacgcatga aggttatcgc 1200
tgtacttaac cagaaaggcg ggtcaggcaa gacgaccatc gcaacccatc tagcccgcgc 1260tgtacttaac cagaaaggcg ggtcaggcaa gacgaccatc gcaacccatc tagcccgcgc 1260
cctgcaactc gccggggccg atgttctgtt agtcgattcc gatccccagg gcagtgcccg 1320cctgcaactc gccggggccg atgttctgtt agtcgattcc gatccccagg gcagtgcccg 1320
cgattgggcg gccgtgcggg aagatcaacc gctaaccgtt gtcggcatcg accgcccgac 1380cgattgggcg gccgtgcggg aagatcaacc gctaaccgtt gtcggcatcg accgcccgac 1380
gattgaccgc gacgtgaagg ccatcggccg gcgcgacttc gtagtgatcg acggagcgcc 1440gattgaccgc gacgtgaagg ccatcggccg gcgcgacttc gtagtgatcg acggagcgcc 1440
ccaggcggcg gacttggctg tgtccgcgat caaggcagcc gacttcgtgc tgattccggt 1500ccaggcggcg gacttggctg tgtccgcgat caaggcagcc gacttcgtgc tgattccggt 1500
gcagccaagc ccttacgaca tatgggccac cgccgacctg gtggagctgg ttaagcagcg 1560gcagccaagc ccttacgaca tatgggccac cgccgacctg gtggagctgg ttaagcagcg 1560
cattgaggtc acggatggaa ggctacaagc ggcctttgtc gtgtcgcggg cgatcaaagg 1620cattgaggtc acggatggaa ggctacaagc ggcctttgtc gtgtcgcggg cgatcaaagg 1620
cacgcgcatc ggcggtgagg ttgccgaggc gctggccggg tacgagctgc ccattcttga 1680cacgcgcatc ggcggtgagg ttgccgaggc gctggccggg tacgagctgc ccattcttga 1680
gtcccgtatc acgcagcgcg tgagctaccc aggcactgcc gccgccggca caaccgttct 1740gtcccgtatc acgcagcgcg tgagctaccc aggcactgcc gccgccggca caaccgttct 1740
tgaatcagaa cccgagggcg acgctgcccg cgaggtccag gcgctggccg ctgaaattaa 1800tgaatcagaa cccgagggcg acgctgcccg cgaggtccag gcgctggccg ctgaaattaa 1800
atcaaaactc atttgagtta atgaggtaaa gagaaaatga gcaaaagcac aaacacgcta 1860atcaaaactc atttgagtta atgaggtaaa gagaaaatga gcaaaagcac aaacacgcta 1860
agtgccggcc gtccgagcgc acgcagcagc aaggctgcaa cgttggccag cctggcagac 1920agtgccggcc gtccgagcgc acgcagcagc aaggctgcaa cgttggccag cctggcagac 1920
acgccagcca tgaagcgggt caactttcag ttgccggcgg aggatcacac caagctgaag 1980acgccagcca tgaagcgggt caactttcag ttgccggcgg aggatcacac caagctgaag 1980
atgtacgcgg tacgccaagg caagaccatt accgagctgc tatctgaata catcgcgcag 2040atgtacgcgg tacgccaagg caagaccatt accgagctgc tatctgaata catcgcgcag 2040
ctaccagagt aaatgagcaa atgaataaat gagtagatga attttagcgg ctaaaggagg 2100ctaccagagt aaatgagcaa atgaataaat gagtagatga attttagcgg ctaaaggagg 2100
cggcatggaa aatcaagaac aaccaggcac cgacgccgtg gaatgcccca tgtgtggagg 2160cggcatggaa aatcaagaac aaccaggcac cgacgccgtg gaatgcccca tgtgtggagg 2160
aacgggcggt tggccaggcg taagcggctg ggttgtctgc cggccctgca atggcactgg 2220aacgggcggt tggccaggcg taagcggctg ggttgtctgc cggccctgca atggcactgg 2220
aacccccaag cccgaggaat cggcgtgagc ggtcgcaaac catccggccc ggtacaaatc 2280aacccccaag cccgaggaat cggcgtgagc ggtcgcaaac catccggccc ggtacaaatc 2280
ggcgcggcgc tgggtgatga cctggtggag aagttgaagg ccgcgcaggc cgcccagcgg 2340ggcgcggcgc tgggtgatga cctggtggag aagttgaagg ccgcgcaggc cgcccagcgg 2340
caacgcatcg aggcagaagc acgccccggt gaatcgtggc aagcggccgc tgatcgaatc 2400caacgcatcg aggcagaagc acgccccggt gaatcgtggc aagcggccgc tgatcgaatc 2400
cgcaaagaat cccggcaacc gccggcagcc ggtgcgccgt cgattaggaa gccgcccaag 2460cgcaaagaat cccggcaacc gccggcagcc ggtgcgccgt cgattaggaa gccgcccaag 2460
ggcgacgagc aaccagattt tttcgttccg atgctctatg acgtgggcac ccgcgatagt 2520ggcgacgagc aaccagattt tttcgttccg atgctctatg acgtgggcac ccgcgatagt 2520
cgcagcatca tggacgtggc cgttttccgt ctgtcgaagc gtgaccgacg agctggcgag 2580cgcagcatca tggacgtggc cgttttccgt ctgtcgaagc gtgaccgacg agctggcgag 2580
gtgatccgct acgagcttcc agacgggcac gtagaggttt ccgcagggcc ggccggcatg 2640gtgatccgct acgagcttcc agacgggcac gtagaggttt ccgcagggcc ggccggcatg 2640
gccagtgtgt gggattacga cctggtactg atggcggttt cccatctaac cgaatccatg 2700gccagtgtgt gggattacga cctggtactg atggcggttt cccatctaac cgaatccatg 2700
aaccgatacc gggaagggaa gggagacaag cccggccgcg tgttccgtcc acacgttgcg 2760aaccgatacc gggaagggaa gggagacaag cccggccgcg tgttccgtcc acacgttgcg 2760
gacgtactca agttctgccg gcgagccgat ggcggaaagc agaaagacga cctggtagaa 2820gacgtactca agttctgccg gcgagccgat ggcggaaagc agaaagacga cctggtagaa 2820
acctgcattc ggttaaacac cacgcacgtt gccatgcagc gtacgaagaa ggccaagaac 2880acctgcattc ggttaaacac cacgcacgtt gccatgcagc gtacgaagaa ggccaagaac 2880
ggccgcctgg tgacggtatc cgagggtgaa gccttgatta gccgctacaa gatcgtaaag 2940ggccgcctgg tgacggtatc cgagggtgaa gccttgatta gccgctacaa gatcgtaaag 2940
agcgaaaccg ggcggccgga gtacatcgag atcgagctag ctgattggat gtaccgcgag 3000agcgaaaccg ggcggccgga gtacatcgag atcgagctag ctgattggat gtaccgcgag 3000
atcacagaag gcaagaaccc ggacgtgctg acggttcacc ccgattactt tttgatcgat 3060atcacagaag gcaagaaccc ggacgtgctg acggttcacc ccgattactt tttgatcgat 3060
cccggcatcg gccgttttct ctaccgcctg gcacgccgcg ccgcaggcaa ggcagaagcc 3120cccggcatcg gccgttttct ctaccgcctg gcacgccgcg ccgcaggcaa ggcagaagcc 3120
agatggttgt tcaagacgat ctacgaacgc agtggcagcg ccggagagtt caagaagttc 3180agatggttgt tcaagacgat ctacgaacgc agtggcagcg ccggagagtt caagaagttc 3180
tgtttcaccg tgcgcaagct gatcgggtca aatgacctgc cggagtacga tttgaaggag 3240tgtttcaccg tgcgcaagct gatcgggtca aatgacctgc cggagtacga tttgaaggag 3240
gaggcggggc aggctggccc gatcctagtc atgcgctacc gcaacctgat cgagggcgaa 3300gaggcggggc aggctggccc gatcctagtc atgcgctacc gcaacctgat cgagggcgaa 3300
gcatccgccg gttcctaatg tacggagcag atgctagggc aaattgccct agcaggggaa 3360gcatccgccg gttcctaatg tacggagcag atgctagggc aaattgccct agcaggggaa 3360
aaaggtcgaa aaggtctctt tcctgtggat agcacgtaca ttgggaaccc aaagccgtac 3420aaaggtcgaa aaggtctctt tcctgtggat agcacgtaca ttgggaaccc aaagccgtac 3420
attgggaacc ggaacccgta cattgggaac ccaaagccgt acattgggaa ccggtcacac 3480attgggaacc ggaacccgta cattgggaac ccaaagccgt attgggaa ccggtcacac 3480
atgtaagtga ctgatataaa agagaaaaaa ggcgattttt ccgcctaaaa ctctttaaaa 3540atgtaagtga ctgatataaa agagaaaaaa ggcgattttt ccgcctaaaa ctctttaaaa 3540
cttattaaaa ctcttaaaac ccgcctggcc tgtgcataac tgtctggcca gcgcacagcc 3600ctttattaaaa ctcttaaaac ccgcctggcc tgtgcataac tgtctggcca gcgcacagcc 3600
gaagagctgc aaaaagcgcc tacccttcgg tcgctgcgct ccctacgccc cgccgcttcg 3660gaagagctgc aaaaagcgcc tacccttcgg tcgctgcgct ccctacgccc cgccgcttcg 3660
cgtcggccta tcgcggccgc tggccgctca aaaatggctg gcctacggcc aggcaatcta 3720cgtcggccta tcgcggccgc tggccgctca aaaatggctg gcctacggcc aggcaatcta 3720
ccagggcgcg gacaagccgc gccgtcgcca ctcgaccgcc ggcgcccaca tcaaggcacc 3780ccagggcgcg gacaagccgc gccgtcgcca ctcgaccgcc ggcgcccaca tcaaggcacc 3780
ctgcctcgcg cgtttcggtg atgacggtga aaacctctga cacatgcagc tcccggagac 3840ctgcctcgcg cgtttcggtg atgacggtga aaacctctga cacatgcagc tcccggagac 3840
ggtcacagct tgtctgtaag cggatgccgg gagcagacaa gcccgtcagg gcgcgtcagc 3900ggtcacagct tgtctgtaag cggatgccgg gagcagacaa gcccgtcagg gcgcgtcagc 3900
gggtgttggc gggtgtcggg gcgcagccat gacccagtca cgtagcgata gcggagtgta 3960gggtgttggc gggtgtcggg gcgcagccat gacccagtca cgtagcgata gcggagtgta 3960
tactggctta actatgcggc atcagagcag attgtactga gagtgcacca tatgcggtgt 4020tactggctta actatgcggc atcagagcag attgtactga gagtgcacca tatgcggtgt 4020
gaaataccgc acagatgcgt aaggagaaaa taccgcatca ggcgctcttc cgcttcctcg 4080gaaataccgc acagatgcgt aaggagaaaa taccgcatca ggcgctcttc cgcttcctcg 4080
ctcactgact cgctgcgctc ggtcgttcgg ctgcggcgag cggtatcagc tcactcaaag 4140ctcactgact cgctgcgctc ggtcgttcgg ctgcggcgag cggtatcagc tcactcaaag 4140
gcggtaatac ggttatccac agaatcaggg gataacgcag gaaagaacat gtgagcaaaa 4200gcggtaatac ggttatccac agaatcaggg gataacgcag gaaagaacat gtgagcaaaa 4200
ggccagcaaa aggccaggaa ccgtaaaaag gccgcgttgc tggcgttttt ccataggctc 4260ggccagcaaa aggccaggaa ccgtaaaaag gccgcgttgc tggcgttttt ccataggctc 4260
cgcccccctg acgagcatca caaaaatcga cgctcaagtc agaggtggcg aaacccgaca 4320cgcccccctg acgagcatca caaaaatcga cgctcaagtc agaggtggcg aaacccgaca 4320
ggactataaa gataccaggc gtttccccct ggaagctccc tcgtgcgctc tcctgttccg 4380ggactataaa gataccaggc gtttccccct ggaagctccc tcgtgcgctc tcctgttccg 4380
accctgccgc ttaccggata cctgtccgcc tttctccctt cgggaagcgt ggcgctttct 4440accctgccgc ttaccggata cctgtccgcc tttctccctt cgggaagcgt ggcgctttct 4440
catagctcac gctgtaggta tctcagttcg gtgtaggtcg ttcgctccaa gctgggctgt 4500catagctcac gctgtaggta tctcagttcg gtgtaggtcg ttcgctccaa gctgggctgt 4500
gtgcacgaac cccccgttca gcccgaccgc tgcgccttat ccggtaacta tcgtcttgag 4560gtgcacgaac cccccgttca gcccgaccgc tgcgccttat ccggtaacta tcgtcttgag 4560
tccaacccgg taagacacga cttatcgcca ctggcagcag ccactggtaa caggattagc 4620tccaacccgg taagacacga cttatcgcca ctggcagcag ccactggtaa caggattagc 4620
agagcgaggt atgtaggcgg tgctacagag ttcttgaagt ggtggcctaa ctacggctac 4680agagcgaggt atgtaggcgg tgctacagag ttcttgaagt ggtggcctaa ctacggctac 4680
actagaagga cagtatttgg tatctgcgct ctgctgaagc cagttacctt cggaaaaaga 4740actagaagga cagtatttgg tatctgcgct ctgctgaagc cagttacctt cggaaaaaga 4740
gttggtagct cttgatccgg caaacaaacc accgctggta gcggtggttt ttttgtttgc 4800gttggtagct cttgatccgg caaacaaacc accgctggta gcggtggttt ttttgtttgc 4800
aagcagcaga ttacgcgcag aaaaaaagga tctcaagaag atcctttgat cttttctacg 4860aagcagcaga ttacgcgcag aaaaaaagga tctcaagaag atcctttgat cttttctacg 4860
gggtctgacg ctcagtggaa cgaaaactca cgttaaggga ttttggtcat gcatgatata 4920gggtctgacg ctcagtggaa cgaaaactca cgttaaggga ttttggtcat gcatgatata 4920
tctcccaatt tgtgtagggc ttattatgca cgcttaaaaa taataaaagc agacttgacc 4980tctcccaatt tgtgtagggc ttattatgca cgcttaaaaa taataaaagc agacttgacc 4980
tgatagtttg gctgtgagca attatgtgct tagtgcatct aatcgcttga gttaacgccg 5040tgatagtttg gctgtgagca attatgtgct tagtgcatct aatcgcttga gttaacgccg 5040
gcgaagcggc gtcggcttga acgaatttct agctagagga tcgcaccaat aactgcctta 5100gcgaagcggc gtcggcttga acgaatttct agctagagga tcgcaccaat aactgcctta 5100
aaaaaattac gccccgccct gccactcatc gcagtactgt tgtaattcat taagcattct 5160aaaaaattac gccccgccct gccactcatc gcagtactgt tgtaattcat taagcattct 5160
gccgacatgg aagccatcac aaacggcatg atgaacctga atcgccagcg gcatcagcac 5220gccgacatgg aagccatcac aaacggcatg atgaacctga atcgccagcg gcatcagcac 5220
cttgtcgcct tgcgtataat atttgcccat tgtgaaaacg ggggcgaaga agttgtccat 5280cttgtcgcct tgcgtataat atttgcccat tgtgaaaacg ggggcgaaga agttgtccat 5280
attggccacg tttaaatcaa aactggtgaa actcacccag ggattggctg agacgaaaaa 5340attggccacg tttaaatcaa aactggtgaa actcacccag ggattggctg agacgaaaaa 5340
catattctca ataaaccctt tagggaaata ggccaggttt tcaccgtaac acgccacatc 5400catattctca ataaaccctt tagggaaata ggccaggttt tcaccgtaac acgccacatc 5400
ttgcgaatat atgtgtagaa actgccggaa atcgtcgtgg tattcactcc agagcgatga 5460ttgcgaatat atgtgtagaa actgccggaa atcgtcgtgg tattcactcc agagcgatga 5460
aaacgtttca gtttgctcat ggaaaacggt gtaacaaggg tgaacactat cccatatcac 5520aaacgtttca gtttgctcat ggaaaacggt gtaacaaggg tgaacactat cccatatcac 5520
cagctcaccg tctttcattg ccatacggaa ctccggatga gcattcatca ggcgggcaag 5580cagctcaccg tctttcattg ccatacggaa ctccggatga gcattcatca ggcgggcaag 5580
aatgtgaata aaggccggat aaaacttgtg cttatttttc tttacggtct ttaaaaaggc 5640aatgtgaata aaggccggat aaaacttgtg cttatttttc tttacggtct ttaaaaaggc 5640
cgtaatatcc agctgaacgg tctggttata ggtacattga gcaactgact gaaatgcctc 5700cgtaatatcc agctgaacgg tctggttata ggtacattga gcaactgact gaaatgcctc 5700
aaaatgttct ttacgatgcc attgggatat atcaacggtg gtatatccag tgattttttt 5760aaaatgttct ttacgatgcc attgggatat atcaacggtg gtatatccag tgattttttt 5760
ctccatgatg tttaactttg ttttagggcg actgccctgc tgcgtaacat cgttgctgct 5820ctccatgatg tttaactttg ttttagggcg actgccctgc tgcgtaacat cgttgctgct 5820
ccataacatc aaacatcgac ccacggcgta acgcgcttgc tgcttggatg cccgaggcat 5880ccataacatc aaacatcgac ccacggcgta acgcgcttgc tgcttggatg cccgaggcat 5880
agactgtacc ccaaaaaaac atgtcataac aagaagccat gaaaaccgcc actgcgccgt 5940agactgtacc ccaaaaaaac atgtcataac aagaagccat gaaaaccgcc actgcgccgt 5940
taccaccgct gcgttcggtc aaggttctgg accagttgcg tgacggcagt tacgctactt 6000taccaccgct gcgttcggtc aaggttctgg accacgttgcg tgacggcagt tacgctactt 6000
gcattacagc ttacgaaccg aacgaggctt atgtccactg ggttcgtgcc cgaattgatc 6060gcattacagc ttacgaaccg aacgaggctt atgtccactg ggttcgtgcc cgaattgatc 6060
acaggcagca acgctctgtc atcgttacaa tcaacatgct accctccgcg agatcatccg 6120acaggcagca acgctctgtc atcgttacaa tcaacatgct accctccgcg agatcatccg 6120
tgtttcaaac ccggcagctt agttgccgtt cttccgaata gcatcggtaa catgagcaaa 6180tgtttcaaac ccggcagctt agttgccgtt cttccgaata gcatcggtaa catgagcaaa 6180
gtctgccgcc ttacaacggc tctcccgctg acgccgtccc ggactgatgg gctgcctgta 6240gtctgccgcc ttacaacggc tctcccgctg acgccgtccc ggactgatgg gctgcctgta 6240
tcgagtggtg attttgtgcc gagctgccgg tcggggagct gttggctggc tggtggcagg 6300tcgagtggtg attttgtgcc gagctgccgg tcggggagct gttggctggc tggtggcagg 6300
atatattgtg gtgtaaacaa attgacgctt agacaactta ataacacatt gcggacgttt 6360atatattgtg gtgtaaacaa attgacgctt agacaactta ataacacatt gcggacgttt 6360
ttaatgtact gaattaacgc cgaattaatt cgggggatct atagggactt taggtgatct 6420ttaatgtact gaattaacgc cgaattaatt cgggggatct atagggactt taggtgatct 6420
ggattttagt actggatttt ggttttagga attagaaatt ttattgatag aagtatttta 6480ggattttagt actggatttt ggttttagga attagaaatt ttatgatag aagtatttta 6480
caaatacaaa tacatactaa gggtttctta tatgctcaac acgtgagcga aaccctataa 6540caaatacaaa tacatactaa gggtttctta tatgctcaac acgtgagcga aaccctataa 6540
gaaccctaat tcccttatct gggaactact cacacattat tatggagaaa ctcgatgtcg 6600gaaccctaat tcccttatct gggaactact cacacattat tatggagaaa ctcgatgtcg 6600
atcgactcta gctagaggat cgatccgaac cccagagtcc cgctcagaag aactcgtcaa 6660atcgactcta gctagaggat cgatccgaac cccagagtcc cgctcagaag aactcgtcaa 6660
gaaggcgata gaaggcgatg cgctgcgaat cgggagcggc gataccgtaa agcacgagga 6720gaaggcgata gaaggcgatg cgctgcgaat cgggagcggc gataccgtaa agcacgagga 6720
agcggtcagc ccattcgccg ccaagctctt cagcaatatc acgggtagcc aacgctatgt 6780agcggtcagc ccattcgccg ccaagctctt cagcaatatc acgggtagcc aacgctatgt 6780
cctgatagcg gtccgccaca cccagccggc cacagtcgat gaatccagaa aagcggccat 6840cctgatagcg gtccgccaca cccagccggc cacagtcgat gaatccagaa aagcggccat 6840
tttccaccat gatattcggc aagcaggcat cgccatgtgt cacgacgaga tcctcgccgt 6900tttccaccat gatattcggc aagcaggcat cgccatgtgt cacgacgaga tcctcgccgt 6900
cgggcatgcg cgcaaagaag gattacctct aaacaagtgt acctgtgcat tctgggtaaa 6960cgggcatgcg cgcaaagaag gattacctct aaacaagtgt acctgtgcat tctgggtaaa 6960
cgactcatag gagagttgta aaaaagtttc ggccggcgta ttgggtgtta cggagcattc 7020cgactcatag gagagttgta aaaaagtttc ggccggcgta ttgggtgtta cggagcattc 7020
actaggcaac catggttact attgtatacc atcttagtag gaatgatttc gaggtttata 7080actaggcaac catggttact attgtatacc atcttagtag gaatgatttc gaggtttata 7080
cctacgatga atgtgtgtcc tgtaggcttg agagttcaag gaagaaacat gcaattatct 7140cctacgatga atgtgtgtcc tgtaggcttg agagttcaag gaagaaacat gcaattatct 7140
ttgcgaaccc agggctggtg acggaatttt catagtcaag ctatcagagt aaagaagagg 7200ttgcgaaccc agggctggtg acggaatttt catagtcaag ctatcagagt aaagaagagg 7200
agcatgtcaa agtacaatta gagacaaata tatagtcgcg tggagccaag agcggattcc 7260agcatgtcaa agtacaatta gagacaaata tatagtcgcg tggagccaag agcggattcc 7260
tcagtctcgt aggtctcttg acgaccgttg atctgcttga tctcgtctcc cgaaaatgaa 7320tcagtctcgt aggtctcttg acgaccgttg atctgcttga tctcgtctcc cgaaaatgaa 7320
aatagctctg ctaagctatt cttctcttcg ccggagcctg aaggcgttac taggttgcag 7380aatagctctg ctaagctatt cttctcttcg ccggagcctg aaggcgttac taggttgcag 7380
tcaatgcatt aatgcattgc agatgagctg tatctggaag aggtaaaccc gaaaacgcgt 7440tcaatgcatt aatgcattgc agatgagctg tatctggaag aggtaaaccc gaaaacgcgt 7440
tttattcttg ttgacatgga gctattaaat cactagaagg cactctttgc tgcttggaca 7500tttattcttg ttgacatgga gctattaaat cactagaagg cactctttgc tgcttggaca 7500
aatgaacgta tcttatcgag atcctgaaca ccatttgtct caactccgga gctgacatcg 7560aatgaacgta tcttatcgag atcctgaaca ccatttgtct caactccgga gctgacatcg 7560
acaccaacga tcttatatcc agattcgtca agctgtttga tgatttcagt aacgttaagt 7620acaccaacga tcttatatcc agattcgtca agctgtttga tgatttcagt aacgttaagt 7620
ggatccggtc ggcatctact ctattccttt gccctcggac gagtgctggg gcgtcggttt 7680ggatccggtc ggcatctact ctattccttt gccctcggac gagtgctggg gcgtcggttt 7680
ccactatcgg cgagtacttc tacacagcca tcggtccaga cggccgcgct tctgcgggcg 7740ccactatcgg cgagtacttc tacacagcca tcggtccaga cggccgcgct tctgcgggcg 7740
atttgtgtac gcccgacagt cccggctccg gatcggacga ttgcgtcgca tcgaccctgc 7800atttgtgtac gcccgacagt cccggctccg gatcggacga ttgcgtcgca tcgaccctgc 7800
gcccaagctg catcatcgaa attgccgtca accaagctct gatagagttg gtcaagacca 7860gcccaagctg catcatcgaa attgccgtca accaagctct gatagagttg gtcaagacca 7860
atgcggagca tatacgcccg gagccgcggc gatcctgcaa gctccggatg cctccgctcg 7920atgcggagca tatacgcccg gagccgcggc gatcctgcaa gctccggatg cctccgctcg 7920
aagtagcgcg tctgctgctc catacaagcc aaccacggcc tccagaagaa gatgttggcg 7980aagtagcgcg tctgctgctc catacaagcc aaccacggcc tccagaagaa gatgttggcg 7980
acctcgtatt gggaatcccc gaacatcgcc tcgctccagt caatgaccgc tgttatgcgg 8040acctcgtatt gggaatcccc gaacatcgcc tcgctccagt caatgaccgc tgttatgcgg 8040
ccattgtccg tcaggacatt gttggagccg aaatccgcgt gcacgaggtg ccggacttcg 8100ccattgtccg tcaggacatt gttggagccg aaatccgcgt gcacgaggtg ccggacttcg 8100
gggcagtcct cggcccaaag catcagctca tcgagagcct gcgcgacgga cgcactgacg 8160gggcagtcct cggcccaaag catcagctca tcgagagcct gcgcgacgga cgcactgacg 8160
gtgtcgtcca tcacagtttg ccagtgatac acatggggat cagcaatcgc gcatatgaaa 8220gtgtcgtcca tcacagtttg ccagtgatac acatggggat cagcaatcgc gcatatgaaa 8220
tcacgccatg tagtgtattg accgattcct tgcggtccga atgggccgaa cccgctcgtc 8280tcacgccatg tagtgtattg accgattcct tgcggtccga atgggccgaa cccgctcgtc 8280
tggctaagat cggccgcagc gatcgcatcc atggcctccg cgaccggctg cagaacagcg 8340tggctaagat cggccgcagc gatcgcatcc atggcctccg cgaccggctg cagaacagcg 8340
ggcagttcgg tttcaggcag gtcttgcaac gtgacaccct gtgcacggcg ggagatgcaa 8400ggcagttcgg tttcaggcag gtcttgcaac gtgacaccct gtgcacggcg ggagatgcaa 8400
taggtcaggc tctcgctgaa ttccccaatg tcaagcactt ccggaatcgg gagcgcggcc 8460taggtcaggc tctcgctgaa ttccccaatg tcaagcactt ccggaatcgg gagcgcggcc 8460
gatgcaaagt gccgataaac ataacgatct ttgtagaaac catcggcgca gctatttacc 8520gatgcaaagt gccgataaac ataacgatct ttgtagaaac catcggcgca gctatttacc 8520
cgcaggacat atccacgccc tcctacatcg aagctgaaag cacgagattc ttcgccctcc 8580cgcaggacat atccacgccc tcctacatcg aagctgaaag cacgagattc ttcgccctcc 8580
gagagctgca tcaggtcgga gacgctgtcg aacttttcga tcagaaactt ctcgacagac 8640gagagctgca tcaggtcgga gacgctgtcg aacttttcga tcagaaactt ctcgacagac 8640
gtcgcggtga gttcaggctt tttcatatcg atgcttgggt agaataggta agtcagattg 8700gtcgcggtga gttcaggctt tttcatatcg atgcttgggt agaataggta agtcagattg 8700
aatctgaaat aaagggagga agggcgaact taagaaggta tgaccgggtc gttcacttac 8760aatctgaaat aaagggagga agggcgaact taagaaggta tgaccgggtc gttcacttac 8760
cttgcttgac aaacgcacaa gttatcgtgc accaagcagc agatgataat aatgtcctcg 8820cttgcttgac aaacgcacaa gttatcgtgc accaagcagc agatgataat aatgtcctcg 8820
ttcctgtctg ctaataagag tcacacttcg agcgccgccg ctactgctta caagtgggct 8880ttcctgtctg ctaataagag tcacacttcg agcgccgccg ctactgctta caagtgggct 8880
gatctgacca gttgcctaaa tgaaccatct tgtcaaacga cacaaatttt gtgatccgcc 8940gatctgacca gttgcctaaa tgaaccatct tgtcaaacga cacaaatttt gtgatccgcc 8940
tggacgacta aaccaaaata gcattgatgt gttgacctcc actagctcca gccaagccca 9000tggacgacta aaccaaaata gcattgatgt gttgacctcc actagctcca gccaagccca 9000
aaaatgctcc ttcaatatca tcttctggtc gacaaagaag gattacctct aaacaagtgt 9060aaaatgctcc ttcaatatca tcttctggtc gacaaagaag gattacctct aaacaagtgt 9060
acctgtgcat tctgggtaaa cgactcatag gagagttgta aaaaagtttc ggccggcgta 9120acctgtgcat tctgggtaaa cgactcatag gagagttgta aaaaagtttc ggccggcgta 9120
ttgggtgtta cggagcattc actaggcaac catggttact attgtatacc atcttagtag 9180ttgggtgtta cggagcattc actaggcaac catggttact attgtatacc atcttagtag 9180
gaatgatttc gaggtttata cctacgatga atgtgtgtcc tgtaggcttg agagttcaag 9240gaatgatttc gaggtttata cctacgatga atgtgtgtcc tgtaggcttg agagttcaag 9240
gaagaaacat gcaattatct ttgcgaaccc agggctggtg acggaatttt catagtcaag 9300gaagaaacat gcaattatct ttgcgaaccc agggctggtg acggaatttt catagtcaag 9300
ctatcagagt aaagaagagg agcatgtcaa agtacaatta gagacaaata tatagtcgcg 9360ctatcagagt aaagaagagg agcatgtcaa agtacaatta gagacaaata tatagtcgcg 9360
tggagccaag agcggattcc tcagtctcgt aggtctcttg acgaccgttg atctgcttga 9420tggagccaag agcggattcc tcagtctcgt aggtctcttg acgaccgttg atctgcttga 9420
tctcgtctcc cgaaaatgaa aatagctctg ctaagctatt cttctcttcg ccggagcctg 9480tctcgtctcc cgaaaatgaa aatagctctg ctaagctatt cttctcttcg ccggagcctg 9480
aaggcgttac taggttgcag tcaatgcatt aatgcattgc agatgagctg tatctggaag 9540aaggcgttac taggttgcag tcaatgcatt aatgcattgc agatgagctg tatctggaag 9540
aggtaaaccc gaaaacgcgt tttattcttg ttgacatgga gctattaaat catctagagg 9600aggtaaaccc gaaaacgcgt tttattcttg ttgacatgga gctattaaat catctagagg 9600
tcaccgagct cggtaccccc gggcaattga gatctgagat taaaatagat aaggaaaaga 9660tcaccgagct cggtaccccc gggcaattga gatctgagat taaaatagat aaggaaaaga 9660
aagtgaaaag aaattcggaa gcatggcaca ttcttctttt tataaataca tgcctgactt 9720aagtgaaaag aaattcggaa gcatggcaca ttcttctttt tataaataca tgcctgactt 9720
tctttttcca tcgatatgat atatgcatat gatagatata caagcaatct tcttcaagga 9780tctttttcca tcgatatgat atatgcatat gatagatata caagcaatct tcttcaagga 9780
gtttgaaatt ttgtcctcca ggagcaaaaa aaagtttttt tttatacatg tttgtacaca 9840gtttgaaatt ttgtcctcca ggagcaaaaa aaagtttttt tttatacatg tttgtacaca 9840
agaatagtta ccaatttgct ttggtcttac gtgctgcaag tttatatcgt tttcaatttc 9900agaatagtta ccaatttgct ttggtcttac gtgctgcaag tttatatcgt tttcaatttc 9900
tttgtcttta cattttcttt gtcctttatc tttcctcatt tagtctttgg gagaattagg 9960tttgtcttta cattttcttt gtcctttatc tttcctcatt tagtctttgg gagaattagg 9960
aaaagggagc ggaaaggtaa gaaatgcttg cgtattttac taattcggca aacatccaat 10020aaaagggagc ggaaaggtaa gaaatgcttg cgtattttac taattcggca aacatccaat 10020
ttggcaaaca gcagcctgtg caacgctctc gagatgacag tatctttgat tacactctaa 10080ttggcaaaca gcagcctgtg caacgctctc gagatgacag tatctttgat tacactctaa 10080
atctcgatga cccgaccaaa aagagcgaac aaagaaataa tcttgtgcat tcgaatatga 10140atctcgatga cccgaccaaa aagagcgaac aaagaaataa tcttgtgcat tcgaatatga 10140
tggaagattt tttccccctt attctaaatg ttgacatagc gtgtatgtta tataaacaaa 10200tggaagattt tttccccctt attctaaatg ttgacatagc gtgtatgtta tataaacaaa 10200
aagaaattgt acaaactttc ttttcttctc tttttatttt atctcgactc tgggtcacta 10260aagaaattgt acaaactttc ttttcttctc tttttatttt atctcgactc tgggtcacta 10260
gtgacccaga gtcactaaat tatcgaggta cagttgttct tattttgcgc aaaagcccaa 10320gtgacccaga gtcactaaat tatcgaggta cagttgttct tattttgcgc aaaagcccaa 10320
atggagaagg tctatgtcga gtagacgtta cgtaattacg taactgacgt tggatcattg 10380atggagaagg tctatgtcga gtagacgtta cgtaattacg taactgacgt tggatcattg 10380
cggaagtccg aggccgcttc tcttcttatc gaatcgtctc gataaaagta aaagccctct 10440cggaagtccg aggccgcttc tcttcttatc gaatcgtctc gataaaagta aaagccctct 10440
gctctagttc gtctagttgc cagcagttct ctggatgctc tgactcctta ggcgagaacc 10500gctctagttc gtctagttgc cagcagttct ctggatgctc tgactcctta ggcgagaacc 10500
gaggtgcgct gatatataaa cagagattaa catgaaactg tacgaggaga agaaatgaga 10560gaggtgcgct gatatataaa cagagattaa catgaaactg tacgaggaga agaaatgaga 10560
ctatcgaact gatactttta aggcagtggt cgggacccaa gcgtttctat taacgtacaa 10620ctatcgaact gatactttta aggcagtggt cgggacccaa gcgtttctat taacgtacaa 10620
agaaggaact tgagagttcg gatgtcctgt gtgtaagtag catccatatt tggagcttta 10680agaaggaact tgagagttcg gatgtcctgt gtgtaagtag catccatatt tggagcttta 10680
gtaaggatga ttctaccata tgttatcatt ggtaccaacg gatcacttac gaggcattgt 10740gtaaggatga ttctaccata tgttatcatt ggtaccaacg gatcacttac gaggcattgt 10740
gggttatgcg gccggctttg aaaaaatgtt gagaggatac tcagcaaatg ggtcttacgt 10800gggttatgcg gccggctttg aaaaaatgtt gagaggatac tcagcaaatg ggtcttacgt 10800
gtccatgtga acaaatctcc attaggaaga aaaagcttgg cactggccgt cgttttacaa 10860gtccatgtga acaaatctcc attaggaaga aaaagcttgg cactggccgt cgttttacaa 10860
cgtcgtgact gggaaaaccc tggcgttacc caacttaatc gccttgcagc acatccccct 10920cgtcgtgact gggaaaaccc tggcgttacc caacttaatc gccttgcagc acatccccct 10920
ttcgccagct ggcgtaatag cgaagaggcc cgcaccgatc gcccttccca acagttgcgc 10980ttcgccagct ggcgtaatag cgaagaggcc cgcaccgatc gcccttccca acagttgcgc 10980
agcctgaatg gcgaatgcta gagcagcttg agcttggatc agattgtcgt ttcccgcctt 11040agcctgaatg gcgaatgcta gagcagcttg agcttggatc agattgtcgt ttcccgcctt 11040
cagtttaaac tatcagtgtt tgacaggata tattggcggg taaacctaag agaaaagagc 11100cagtttaaac tatcagtgtt tgacaggata tattggcggg taaacctaag agaaaagagc 11100
gtttattaga ataacggata tttaaaaggg cgtgaaaagg tttatccgtt cgtccatttg 11160gtttataga ataacggata tttaaaaggg cgtgaaaagg tttatccgtt cgtccatttg 11160
tatgtgcatg ccaaccacag ggttcccctc gggatcaa 11198tatgtgcatg ccaaccacag ggttcccctc gggatcaa 11198
<210> 4<210> 4
<211> 528<211> 528
<212> DNA<212>DNA
<213> 基因crtZ<213> Gene crtZ
<400> 4<400> 4
atgttgtgga tttggaatgc cctgatcgtt ttcgttaccg tgattggcat ggaagtgatt 60atgttgtgga tttggaatgc cctgatcgtt ttcgttaccg tgattggcat ggaagtgatt 60
gctgcactgg cacacaaata catcatgcac ggctggggtt ggggatggca tctttcacat 120gctgcactgg cacacaaata catcatgcac ggctggggtt ggggatggca tctttcacat 120
catgaaccgc gtaaaggtgc gtttgaagtt aacgatcttt atgccgtggt ttttgctgca 180catgaaccgc gtaaaggtgc gtttgaagtt aacgatcttt atgccgtggt ttttgctgca 180
ttatcgatcc tgctgattta tctgggcagt acaggaatgt ggccgctcca gtggattggc 240ttatcgatcc tgctgatta tctgggcagt acaggaatgt ggccgctcca gtggattggc 240
gcaggtatga cggcgtatgg attactctat tttatggtgc acgacgggct ggtgcatcaa 300gcaggtatga cggcgtatgg attackctat tttatggtgc acgacgggct ggtgcatcaa 300
cgttggccat tccgctatat tccacgcaag ggctacctca aacggttgta tatggcgcac 360cgttggccat tccgctatat tccacgcaag ggctacctca aacggttgta tatggcgcac 360
cgtatgcatc acgccgtcag gggcaaagaa ggttgtgttt cttttggctt cctctatgcg 420cgtatgcatc acgccgtcag gggcaaagaa ggttgtgttt cttttggctt cctctatgcg 420
ccgcccctgt caaaacttca ggcgacgctc cgggaaagac atggcgctag agcgggcgct 480ccgcccctgt caaaacttca ggcgacgctc cgggaaagac atggcgctag agcgggcgct 480
gccagagatg cgcagggcgg ggaggatgag cccgcatccg ggaagtaa 528gccagagatg cgcagggcgg ggaggatgag cccgcatccg ggaagtaa 528
<210> 5<210> 5
<211> 816<211> 816
<212> DNA<212>DNA
<213> 基因neoR<213> gene neoR
<400> 5<400> 5
atgagccata ttcaacggga aacgtcttgc tctaggccgc gattaaattc caacatggat 60atgagccata ttcaacggga aacgtcttgc tctaggccgc gattaaattc caacatggat 60
gctgatttat atgggtataa atgggctcgc gataatgtcg ggcaatcagg tgcgacaatc 120gctgatttat atgggtataa atgggctcgc gataatgtcg ggcaatcagg tgcgacaatc 120
tatcgattgt atgggaagcc cgatgcgcca gagttgtttc tgaaacatgg caaaggtagc 180tatcgattgt atgggaagcc cgatgcgcca gagttgtttc tgaaacatgg caaaggtagc 180
gttgccaatg atgttacaga tgagatggtc agactaaact ggctgacgga atttatgcct 240gttgccaatg atgttacaga tgagatggtc agactaaact ggctgacgga atttatgcct 240
cttccgacca tcaagcattt tatccgtact cctgatgatg catggttact caccactgcg 300cttccgacca tcaagcattt tatccgtact cctgatgatg catggttact caccactgcg 300
atccccggga aaacagcatt ccaggtatta gaagaatatc ctgattcagg tgaaaatatt 360atccccggga aaacagcatt ccaggtatta gaagaatatc ctgattcagg tgaaaatatt 360
gttgatgcgc tggcagtgtt cctgcgccgg ttgcattcga ttcctgtttg taattgtcct 420gttgatgcgc tggcagtgtt cctgcgccgg ttgcattcga ttcctgtttg taattgtcct 420
tttaacagcg atcgcgtatt tcgtctcgct caggcgcaat cacgaatgaa taacggtttg 480tttaacagcg atcgcgtatt tcgtctcgct caggcgcaat cacgaatgaa taacggtttg 480
gttgatgcga gtgattttga tgacgagcgt aatggctggc ctgttgaaca agtctggaaa 540gttgatgcga gtgattttga tgacgagcgt aatggctggc ctgttgaaca agtctggaaa 540
gaaatgcata aacttttgcc attctcaccg gattcagtcg tcactcatgg tgatttctca 600gaaatgcata aacttttgcc attctcaccg gattcagtcg tcactcatgg tgatttctca 600
cttgataacc ttatttttga cgaggggaaa ttaataggtt gtattgatgt tggacgagtc 660cttgataacc ttatttttga cgaggggaaa ttaataggtt gtattgatgt tggacgagtc 660
ggaatcgcag accgatacca ggatcttgcc atcctatgga actgcctcgg tgagttttct 720ggaatcgcag accgatacca ggatcttgcc atcctatgga actgcctcgg tgagttttct 720
ccttcattac agaaacggct ttttcaaaaa tatggtattg ataatcctga tatgaataaa 780ccttcattac agaaacggct ttttcaaaaa tatggtattg ataatcctga tatgaataaa 780
ttgcagtttc atttgatgct cgatgagttt ttctaa 816ttgcagtttc atttgatgct cgatgagtttttctaa 816
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510491355.XA CN105154466B (en) | 2015-08-12 | 2015-08-12 | A kind of double gene coexpression recombinant vector and its construction method and the application in Blakeslea trispora |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510491355.XA CN105154466B (en) | 2015-08-12 | 2015-08-12 | A kind of double gene coexpression recombinant vector and its construction method and the application in Blakeslea trispora |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105154466A CN105154466A (en) | 2015-12-16 |
CN105154466B true CN105154466B (en) | 2018-10-30 |
Family
ID=54795511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510491355.XA Expired - Fee Related CN105154466B (en) | 2015-08-12 | 2015-08-12 | A kind of double gene coexpression recombinant vector and its construction method and the application in Blakeslea trispora |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105154466B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1558953A (en) * | 2001-09-26 | 2004-12-29 | 维塔特内有限公司 | Biosynthetic genes of blakeslea trispora beta-carotene that code for lycopene cyclase/phytoene synthase (carRP) and phytoene dehydrogenase (carB) |
CN1759173A (en) * | 2003-01-09 | 2006-04-12 | 巴斯福股份公司 | Method for producing carotenoids or their precursors using genetically modified organisms of the blakeslea genus, carotenoids or their precursors produced by said method and use thereof |
-
2015
- 2015-08-12 CN CN201510491355.XA patent/CN105154466B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1558953A (en) * | 2001-09-26 | 2004-12-29 | 维塔特内有限公司 | Biosynthetic genes of blakeslea trispora beta-carotene that code for lycopene cyclase/phytoene synthase (carRP) and phytoene dehydrogenase (carB) |
CN1759173A (en) * | 2003-01-09 | 2006-04-12 | 巴斯福股份公司 | Method for producing carotenoids or their precursors using genetically modified organisms of the blakeslea genus, carotenoids or their precursors produced by said method and use thereof |
Non-Patent Citations (1)
Title |
---|
丝状真菌转化载体的改进;李继刚等;《河南农业科技》;20130515;第42卷(第5期);第111页右栏最后一段至第112页左栏第1段,图1 * |
Also Published As
Publication number | Publication date |
---|---|
CN105154466A (en) | 2015-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107043779B (en) | Application of a CRISPR/nCas9-mediated site-directed base replacement in plants | |
CN115516097A (en) | Method for producing L-tryptophan by enhancing activity of prephenate dehydratase | |
CN107164255B (en) | A kind of method for constructing recombinant Saccharomyces cerevisiae to produce glucaric acid by fermentation | |
CN109957569A (en) | Base editing system and method based on CPF1 protein | |
CN106929532B (en) | Artificially creating male sterile line of maize and efficient transfer method | |
CN107254485A (en) | A kind of new reaction system for being capable of rapid build plant gene fixed point knockout carrier | |
DK2931918T5 (en) | PROCEDURE FOR IDENTIFYING A CELL WITH INCREASED CONCENTRATION OF A PARTICULAR METABOLIT COMPARED TO THE SIMILAR WILD TYPE CELL ..... | |
CN106701810B (en) | A gene editing system of Corynebacterium glutamicum and its application | |
CN112941087B (en) | Application of corn ZmBES1/BZR1-2 gene in improving plant drought tolerance | |
CN112279903B (en) | A gene for improving rice blast resistance at ear stage and its use | |
CN106591383B (en) | Method for efficiently synthesizing caffeic acid by using catechol as substrate | |
CN111893128A (en) | Method for preparing recombinant eukaryotic mRNA by using prokaryotic transcription system and application thereof | |
KR20150131880A (en) | A microorganism having enhanced productivity of succinate and a method for producing succinate using the same | |
CN106591390B (en) | One kind is from main removing H2O2The enzyme grade method that is unified into rosin element | |
CN108753745B (en) | Ethanol dehydrogenase mutant and encoding gene and application thereof | |
CN110564752B (en) | Application of differential agent technology in enrichment of C.T base substitution cells | |
CN105154466B (en) | A kind of double gene coexpression recombinant vector and its construction method and the application in Blakeslea trispora | |
CN114456963A (en) | Yeast gene engineering bacterium for enhancing homologous recombination capability and application thereof | |
KR20160117584A (en) | Improved microorganisms for succinic acid production | |
CN115087734B (en) | Novel phosphonoacetate hydrolase variants and methods of using same for producing XMP or GMP | |
CN113293173B (en) | Agrobacterium tumefaciens binary expression vector | |
CN106978434A (en) | A kind of method of the expressing protein in Pichia pastoris | |
CN110628794B (en) | Cell enrichment technology of C.T base substitution by taking inactivated screening agent resistance gene as report system and application thereof | |
CN109266631A (en) | A kind of method that genome fixed point knocks out | |
CN106755075A (en) | The method for improving genome editorial efficiency |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181030 Termination date: 20210812 |
|
CF01 | Termination of patent right due to non-payment of annual fee |